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Abstract 
Through ancestral sequence reconstruction (ASR) techniques, ancient enzymes 
can be recreated and biochemically tested, giving insight into the enzymes’ 
evolutionary history.  A previous study by Hobbs et al. (2012) has shown that 
some ancestral 3-isopropylmalate dehydrogenase (IPMDH) enzymes of the 
Bacillus lineage are more catalytically efficient and kinetically stable than extant 
counterparts.  Given these characteristics, this trend raises questions as to why 
ancestral Bacillus IPMDH enzymes have been superseded by catalytically slower 
and less kinetically stable counterparts.  The homology between IPMDH and the 
dehydrogenases of tartrate, malate and isocitrate makes IPMDH an interesting 
model enzyme in terms of the evolution of substrate specificity. 
 
Here, the reconstruction of a 2.7 billion year old enzyme has been attempted to 
extend the reconstruction of IPMDH back to the last common ancestor of the 
Firmicutes.  This reconstruction tested the limits of ASR techniques in terms of 
time and levels of sequence divergence, especially for such a structurally complex 
enzyme.  However, upon expression and purification, the enzyme was found to 
form an inactive, soluble aggregate.  This suggests that current ASR techniques 
are too simplistic to reconstruct the complexity and divergence of IPMDH back as 
far as the last common ancestor of the Firmicutes.  Enzyme evolution was 
investigated with ancestors from the Bacillus genus.  Substrate promiscuity of 
ancestral enzymes was compared to a contemporary counterpart.  It was 
concluded that the ancestral IPMDH enzymes tested do not show additional 
substrate promiscuity when compared to contemporary counterparts.  The fitness 
of organisms carrying the IPMDH ancestors was assessed to establish what effects 
the high turnover rates and kinetic stability possessed by some ancestral IPMDH 
enzymes had on cells when functioning within the normal catalytic pathway for 
leucine.  In vivo, the fastest and most kinetically stable ancestral IPMDH resulted 
in slower growth rates.  This detrimental effect in vivo clarifies why this enzyme 
has been lost over evolutionary time.  The X-ray crystal structure of the most 
recent IPMDH ancestor was also determined at 2.6 Å resolution.  The structure of 
this ancestral IPMDH was found to be similar to other IPMDH structures, 
including the previously solved IPMDH from the last common ancestor of the 
Bacillus.   
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1 Introduction 
1.1 Ancestral Sequence Reconstruction 
Ancestral sequence reconstruction (ASR) has become a powerful tool in the study 
of evolutionary biology.  The technique was first conceived by Pauling and 
Zuckerkandl (1963) when they proposed that it would be possible to infer 
ancestral states from a comparison of modern descendents, and synthesise these 
proteins in the laboratory for biochemical characterisation.  Pauling and 
Zuckerkandl (1963) also performed the first inference, determining the sequence 
of an ancestral mammalian haemoglobin.  However, technical constraints at the 
time prevented physical synthesis of the protein for biochemical characterisation.   
It was not until almost 30 years later that the first reconstructions accompanied 
with synthesis and testing of the ancestral states was achieved.  An ancestral 
ribonuclease from the bovid ruminants (Stackhouse et al. 1990) and lysozyme 
from the Galliformes order of birds (Malcolm et al. 1990) were both inferred and 
reconstructed in the laboratory.  Since this time, ASR has been used to investigate 
a number of evolutionary questions.  Improvements in DNA sequencing, 
computational processing and modelling of the evolutionary processes have seen 
the technique used in increasingly complex reconstructions, enabling access to 
evolutionary history that would otherwise be lost.  Parallel improvements in 
physical reconstruction of the ancestral proteins have also furthered the technique, 
allowing full de novo reconstruction of sequences as opposed to original methods 
which used site directed mutagenesis of functionally important residues.  This 
development is advantageous as the structure-function relationships of the protein 
do not need to be well known in advance to identify relevant residues, and the 
whole ancestral enzyme is able to be reconstructed  (Hall 2006).   
1.1.1 Ancestral Sequence Reconstruction Approaches  
A number of different approaches have been utilised in ASR studies, the major 
methods being maximum parsimony (MP), maximum likelihood (ML) and 
Bayesian inference (BI).  Each of these methods differ in the criteria for optimal 
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phylogenetic tree selection, and as such have different assumptions and biases 
introduced into the final tree used for ancestral inference (Williams et al. 2006).  
The different assumptions introduced in each method make each technique suited 
to different reconstruction time frames and rates of evolution.  All three of the 
methods utilise an alignment of contemporary sequences, and a phylogenetic tree 
summarising the relationships between the species; ML and BI also incorporate 
models of evolution into the inference stages (Zhang & Nei 1997; Cai et al. 2004).  
MP was used in early reconstructions due to the low computational cost, but has 
since been superseded by ML methods which incorporate models to encapsulate 
the complexity of the evolutionary processes being studied.  BI has been the most 
recent method to be proposed, however it is still debated if this approach improves 
the accuracy of the reconstruction (Hall 2006; Hanson-Smith et al. 2010; Hobbs et 
al. 2012).   
1.1.1.1 Maximum Parsimony Methods 
Initial ancestral reconstructions employed the only technique available at the time: 
maximum parsimony inference methods (Fitch 1971).  Examples of 
reconstructions utilising this method include reconstructions of ribonucleases 
from bovid ruminants (Stackhouse et al. 1990) and Artiodactyla (Jermann et al. 
1995), lysozyme from Galliformes (Malcolm et al. 1990) and the reconstruction 
of a retrotransposon promoter sequence (Adey et al. 1994).  In the MP method, 
evolution is considered to follow the most parsimonious route, i.e. the model with 
the least character state changes necessary to explain the contemporary diversity 
(Camin & Sokal 1965).  Each amino acid site is considered separately, and 
ancestral states at the node points are assigned so as to result in the least number 
of character state changes over the tree (Fitch 1971).  As this method does not 
take account of tree branch lengths or biases in amino acid substitution rates, final 
inferences are generally unreliable, especially with high levels of sequence 
divergence (Collins et al. 1994b).  With sequences of low divergence, where 
different rates of evolution and branch lengths are not an issue, MP is sufficient to 
model the phylogeny accurately.  However, MP fails to distinguish between 
equally parsimonious reconstructions when more than one state is predicted with 
equal probability under the model (Zhang & Nei 1997; Cai et al. 2004).  Despite 
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the methods early use, these issues with the basis of this method have seen it 
superseded by more complex approaches which address these errors (Liberles 
2007). 
1.1.1.2 Maximum Likelihood Methods 
Maximum likelihood methods for ancestral reconstructions were developed by 
Yang, Kumar, and Nei (1995).  The major advancement in ML methodology was 
the incorporation of a measurement of accuracy of the inferred ancestral sequence.  
For each possible amino acid at every sequence position in the ancestral nodes, 
the likelihood of the extant sequences given the ancestral states, tree and model of 
evolution is calculated (Hanson-Smith et al. 2010).  The inferred sequence is then 
comprised of the most likely amino acid at each position, and the uncertainty at 
each site gives an overall accuracy of the ancestral sequence.  Having such a 
quantification of the uncertainty is essential to establish confidence in the 
accuracy of ancestral sequences and any other conclusions that may be drawn 
from the reconstruction.   
 
Unlike MP, ML also considers branch lengths and amino acid or nucleotide 
substitution rates in the reconstruction methods (Yang 2006).  Taking account of 
these parameters by incorporating models of evolution, a wide variety of which 
are available, has allowed ML to be applied to a range of evolutionary questions 
(Galtier & Gouy 1998).  As such, compared to MP methods ML offers a more 
realistic approach to the evolutionary process, as well as giving a measure of 
accuracy of the final reconstruction.   
 
One shortcoming of ML is that the method fails to account for sampling errors 
when estimating parameters.  This issue is amplified in smaller datasets, where 
sampling errors become more apparent (Yang 2006).     
1.1.1.3 Hierarchical Bayesian Inference Methods 
Hierarchical BI methods were proposed as a solution to the assumption in ML that 
the alignment, tree, model and model parameters are correct.  BI achieves this by 
summing likelihoods over a range of possible trees and parameters (Hanson-Smith 
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et al. 2010).  BI methods have been developed to integrate uncertainty in the tree 
topology (Pagel et al. 2004), parameters of the model (Schultz & Churchill 1999), 
and combinations of both (Huelsenbeck & Bollback 2001).  These methods have 
also been advanced to incorporate non-constant rates of evolution, and further 
incorporated with the evolutionary models developed for ML methods (Yang 
2006).  Integrating these uncertainties into the reconstruction may improve 
inferences, however this has not yet been conclusively established (Hanson-Smith 
et al. 2010).  
1.1.2 Ancestral Reconstruction Accuracy  
Accuracy in ASR is crucial to the reliability of the technique, and any other 
conclusions that are drawn from the study (Yang 2006).  However, assessment of 
the accuracy of any inferred sequence is by definition difficult, as the actual 
ancestral sequence is not known.  One exception to this has been a known 
bacteriophage T7 phylogeny (Hillis et al. 1992).  In this study, a mutagen was 
used in serial propagation to speed genetic change and create a phylogeny where 
topology and ancestral states were known.  From the descendant viral sequences, 
a phylogenetic tree was constructed and used to infer the ancestral node states by 
the MP method.  This allowed restriction digest maps of the inferred and actual 
ancestors to be compared.  Of the sites this approach covered, 97.3 % of ancestral 
sites were correctly inferred, 1.4 % were incorrectly inferred, and 1.3 % were 
ambiguous.  Of the eighteen incorrectly inferred sites, three involved ancestral 
states that were no longer represented in the descendent sequences.  Such 
occurrences of lost information are likely to be a common occurrence in ASR, but 
are not apparent if ancestral sequences are not available.  In contrast, a similar 
study using a bacteriophage phylogeny and similar methodology gave conflicting 
results (Oakley & Cunningham 2000).  Comparison of inferred and actual viral 
ancestral states revealed high inaccuracy in the inferred sequences for various 
approaches of MP, even when the known parent sequence was used to improve 
the analysis.  Computer simulations indicated that the reconstruction was prone to 
errors due to the fast rates of evolution in the viral sequences and directional bias 
of the character evolution.  To date, this system has not been applied to ML and 
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BI inference methods.  The relevance of this artificially accelerated viral system to 
slowly evolving natural phylogenies over millions of years is also not known.  
 
Despite the recent dominance of ML inference in ASR studies, the accuracy of 
this approach has been questioned.  A number of studies have concluded that BI 
produces more reliable and realistic ancestral sequences.  In a study of 
mitochondrial cytochrome b and cytochrome oxidase subunit 1 from primates, BI 
was found to infer ancestral sequences with nucleotide frequencies more similar 
to extant ratios than ML.  Simulations determined this effect in the ML inference 
to be likely caused by an inherent deterministic bias in the reconstruction.  The 
functionality of ancestral mitochondrial primate tRNAs was also assessed 
theoretically, based on in silico stabilities due to complementary base pairing in 
the folded structure.  Sequences inferred by ML were found to be theoretically 
less functional based on in silico stability than those from BI due to the 
deterministic biases in the ML reconstruction (Krishnan et al. 2004).  Similar 
conclusions have been drawn with regards to the accuracy of BI over ML in the 
assessment of phylogenies produced by sequence evolution simulation programs, 
although the two methods were noted to be similar in accuracy (Hall 2006).  In a 
more complex computer simulation of evolution, Williams, et al (2006) also 
concluded in favour of BI for ancestral reconstruction.  Computational protein 
evolution was used, with purifying selection for variants retaining stability in a 
specified target structure.  Following ASR, in silico thermodynamic properties of 
true and inferred ancestors were compared.  ML, although being more accurate 
overall in the reconstruction, was found to overestimate the thermal stability of 
the ancestors, whereas BI did not.  This effect was concluded to be due to the 
tendency for ML to eliminate residues that are detrimental to stability due to their 
infrequent spread over the tree.  In the BI, the selection of less probable residues 
from the posterior probability at some sites counteracted any overestimation.   
 
The above studies must be interpreted with caution, as they all involve theoretical 
phylogenies and/or theoretical measures of physical parameters of the proteins 
used to approximate fitness.  A test of the accuracy of ML using a true 
bacteriophage phylogeny has been performed, using nested PCR to increase the 
rate of evolution (Sanson et al. 2002).  Predicted ancestors showed 99.46 % – 
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99.87 % sequence similarity to the actual ancestors.  The reconstructions were 
more error prone at deeper branching ancestors, suggesting sequences become less 
reliable with increased age.  As stated in the previous bacteriophage phylogeny 
studies, the relevance of artificially accelerated neutral evolution to actual 
phylogenies must also be considered.   
 
ML has been shown to outperform MP significantly in situations of high sequence 
divergence, especially when the phylogenetic tree includes long branches (Zhang 
& Nei 1997).  However, the accuracy of ML and BI methods is still debated.  
Studies have reported contradictory results about the relative accuracies of ML 
and BI methods.  Using simulated phylogenies, Hanson-Smith et al. (2010) 
concluded that the capacity of BI to incorporate phylogenetic uncertainty into the 
reconstruction was neither necessary or beneficial to the final sequence accuracy.  
Assessment of the accuracy of reconstructed elongation factor Tu has 
demonstrated that ML methods are robust even when there is uncertainty in 
parameters such as the phylogeny and amino acid frequencies of the evolutionary 
model (Gaucher et al. 2008).  Oceanic temperature trends were in agreement with 
the melting temperature (Tm) of the inferred enzymes, lending credibility to the 
accuracy of the inferred properties of the ancestral enzymes.    
 
Only one study has compared the physical properties of enzymes reconstructed by 
ML and BI methods.  Hobbs et al (2012) reconstructed ancestral Bacillus 
isopropylmalate dehydrogenases (IPMDH) inferred by both ML and BI inference 
methods.  The thermodynamic and kinetic properties of the reconstructed 
enzymes were compared to each other, and to contemporary Bacillus enzymes.  
Although enzymes from the same ancestral node inferred with the different 
methods displayed similar levels of thermophily, enzymes inferred by BI had 
abnormally high KM values and were kinetically unstable.  These factors 
suggested that the BI approach was inferring biologically unrealistic ancestral 
states.  By comparison, ancestors inferred by ML methods exhibited 
thermodynamic and kinetic properties similar to those exhibited by extant 
enzymes.       
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A variety of other factors can influence the accuracy of ancestral inference and 
need to be considered in reconstructions.  The number of taxon sequences 
included in the phylogenetic tree and which sequences to include is important to 
the final result.  It has been demonstrated that more taxa are not necessarily better 
for the reconstruction in both MP and ML inferences (Li et al. 2008), but a 
sufficient number of taxa must still be sampled (Salisbury & Kim 2001).  In some 
situations, a single representative extant taxon at the end of a slow evolving deep 
branching lineage results in a more accurate inference compared to a full tree.  
Recombination has also been shown to have a significant effect on ASR.  
Although recombination is more common in eukaryotes and viruses, 
recombination events also occur in bacterial genes.  If ignored, recombination 
events have been shown to have significant effects on the reconstruction and alter 
the biological predictions made from the reconstruction (Arenas & Posada 2010).   
 
Many factors influence the accuracy of ASR.  When properly considered and 
accounted for, ASR studies can give accurate information about ancestral 
molecules, their function and the environment their host inhabited.  However, 
with any result, it must be remembered that the sequences are inferred pseudo-
data, not real observed data and treated with the cautions this necessitates (Yang 
2006).    
1.1.3 Previous Reconstructions 
ASR has been used to reconstruct a variety of ancestral proteins and investigate a 
range of evolutionary questions.  A list of these reconstructions is given in  
Table 1.1. 
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Table 1.1: Summary of ancestral reconstructions reported in the literature.  
Protein reconstructed  Reference 
ATPase (Finnigan et al. 2012) 
β-lactamase  (Risso et al. 2013) 
Carbohydrate binding protein (Krishnan et al. 2004) 
Dehydrogenases (Iwabata et al. 2005) 
 (Thomson et al. 2005) 
 (Hobbs et al. 2012) 
Elongation factor Tu (Gaucher et al. 2003) 
 (Gaucher et al. 2008) 
Fluorescent protein (Ugalde et al. 2004) 
 (Field & Matz 2010) 
Galectin (Konno et al. 2007) 
Glycoside hydrolase (Malcolm et al. 1990) 
 (Voordeckers et al. 2012) 
Ribonuclease (Stackhouse et al. 1990) 
 (Jermann et al. 1995) 
 (Zhang & Rosenberg 2002) 
Serine protease (Chandrasekharan et al. 1996) 
 (Wouters et al. 2003) 
Steroid hormone receptor (Thornton et al. 2003) 
 (Li et al. 2005) 
 (Bridgham, Carroll, & Thornton, 2006) 
 (Ortlund et al. 2007) 
 (Bridgham et al. 2009) 
 (Bridgham et al. 2010) 
 (Carroll et al. 2011) 
Thioredoxin (Perez-Jimenez et al. 2011) 
Visual pigment (Chang et al. 2002) 
 (Shi & Yokoyama 2003) 
 (Chinen et al. 2005) 
 (Yokoyama et al. 2008b) 
 (Yokoyama et al. 2008a) 
 
Of these studies, the majority have been on binding proteins, not enzymes.  
Enzyme reconstruction has the advantage that there is an internal measure of 
Introduction                                                                                                                             
  
9 
 
accuracy in the activity of the reconstructed enzymes.  If too many errors are 
introduced in the inference, the reconstructed enzyme is likely to be non-
functional or exhibit aberrant properties.  The enzymes that have been 
reconstructed to date are generally young, and thus present fewer difficulties in 
the reconstruction as less sequence divergence has occurred.  The three exceptions 
to this are the studies on dehydrogenases (Hobbs et al. 2012), thioredoxins (Perez-
Jimenez et al. 2011) and β-lactamases (Risso et al. 2013).  These studies have 
given insight into the thermal environments the Precambrian ancestors lived in, 
and the biochemical evolution of the enzymes.  Perez-Jimenez, et al. (2011) 
concluded that thioredoxin enzymes have retained the same catalytic mechanisms, 
but have adapted to environmental changes in temperature and oceanic acidity.  β-
lactamase has been reconstructed back to 3 billion years ago (bya), the oldest 
reconstruction of an enzyme (Risso et al. 2013).  Ancestral proteins from this 
reconstruction showed thermal denaturation profiles similar to extant enzymes, 
and broader substrate specificity than contemporary counterparts.  The 
reconstruction of the more structurally complex dehydrogenase (Hobbs et al. 
2012) is discussed later in section 1.3.4. 
1.2 Enzyme Evolution and Fitness  
Enzyme evolution is a complex process, involving changes which impact upon an 
enzymes thermodynamic and kinetic properties, expression level and interaction 
with other molecules.  Enzymatic activity on the native substrate can also be 
affected, or changes can lead to functional divergence by increasing activity 
toward an alternative substrate.  The impact of these changes on fitness at the 
organism level is dictated in the context of the environment and regulatory 
landscape within the cell.  In studying enzyme evolution, random noise and the 
ignorance of selection pressures acting during the adaptation all cloud a complete 
understanding of the processes which have occurred (Arnold et al. 2001).   
 
The study of enzyme evolution is difficult due to the long time scales over which 
change occurs.  Often a directed evolution approach is taken, aiming to mimic 
natural evolution over short time scales to identify adaptive mechanisms (Arnold 
et al. 2001).   The spread of functionality over extant species also provides 
information about the history of related enzymes (Gerlt & Babbitt 2001).  ASR 
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studies have provided a significant tool in the study of protein evolution, allowing 
past evolutionary histories to be reconstituted and analysed (Dean & Thornton 
2007). 
1.2.1 Enzyme Evolution and Substrate Promiscuity  
A commonly held theory of evolution suggests that primitive metabolism was 
driven by a small number of enzymes with broad specificities for a range of 
substrates.  Over time, gene duplication and substrate specialisation have resulted 
in the large array of highly specific enzymes present today (Jensen 1976; Depristo 
2007; Hernandez-Montes et al. 2008).  This diversification and specialisation 
allows for enhanced catalytic speed as well as finer scale control of individual 
metabolic pathways (Copley 2012).  Enzymes today that share the same protein 
fold adapted to different functions or to catalyse the same reactions in different 
pathways provide evidence for this.  For example, the α/β-hydrolase fold is 
present in a variety of enzymes.  Conserved residues in the active sites of these 
enzymes catalyse reactions through nucleophilic attack of the substrate.  However, 
substrates and bonds targeted by the fold differ markedly between different 
enzymes in the superfamily (Ollis et al. 1992; O'Brien & Herschlag 1999).   
 
Substrate promiscuity, coupled with gene duplication, is suggested to be the 
driving factor behind the evolution of new enzymatic functions;  low activity 
toward an alternate substrate provides a starting point for adaptive evolution to 
maximise a new function (O'Brien & Herschlag 1999; James & Tawfik 2001; 
Copley 2012).  Gene duplication precedes diversification as this eliminates the 
functional constrains on one duplicate sequence, allowing for a new function to 
develop (Zhang 2003).  
 
In light of this theory of enzyme evolution, it could be expected that an increase in 
substrate promiscuity would be observed in ancestral enzymes.  This trend has 
been found in the immune defence proteases from mammals (Wouters et al. 
2003).  A reconstructed ancestral protease had broad specificity for the complete 
range of primary substrate specificities found in the descendants.  From this 
ancestor, a range of extant immune defence proteases have arisen with differing 
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primary specificities. A trend from generalist to specialist activity has also been 
described for the reconstruction of ancestral β-lactamases (Risso et al. 2013).  
However, the opposite has been found for an ancestral chymase.  The ancestor of 
the diverse range of chymases showed specific and efficient angiotensin II 
forming activity.  Thus it would appear that in this enzymatic lineage, specificity 
has been lost in favour of a broader activity range (Chandrasekharan et al. 1996).    
1.2.2 Enzyme Evolution in a Cellular Context  
Enzyme evolution is often studied at the level of single proteins.  Characterisation 
of enzymes in vitro, in terms of rate and affinity for substrate, ignores the complex 
interactions occurring in the cellular context.  It has been shown that the evolution 
rate of enzymes is linked to a variety of cellular factors.  Highly connected 
enzymes (sharing product or reactant metabolites with other enzymes) evolve 
more slowly than less connected enzymes, and enzymes with high metabolic flux 
are subject to more evolutionary constraints (Vitkup et al. 2006).  Studying 
enzyme evolution at the single enzyme level provides an oversimplified account 
of these multifaceted influences on the overall fitness of an enzyme in the context 
of a regulated enzymatic pathway (Vitkup et al. 2006).   
 
The issues with this oversimplified view have been illustrated by studies of the 
biological breakdown of glucose.  Despite detailed understanding of the pathway 
and enzymes acting at each step, in vitro kinetics did not correlate to an accurate 
description of in vivo activity for individual enzymes or the pathway as a whole 
(Teusink et al. 2000).  Such discrepancies have been attributed to regulatory 
mechanisms (such as enzyme-enzyme interactions, enzyme modifications, and 
substrate channelling) and the differences between assay media and physiological 
conditions.  Indeed, inclusion of some of these parameters has resulted in more 
accurate modelling of metabolite accumulation in vivo from data measured in 
vitro (van Eunen et al. 2012).   
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1.3 Isopropylmalate Dehydrogenase  
A good candidate enzyme for ASR and the study of enzyme evolution is IPMDH 
(EC 1.1.1.85) from the leucine biosynthetic pathway.  IPMDH is appropriate for 
ASR as it occupies a genomic region that shows little evidence of recombination 
in Bacillus (Didelot et al. 2010).  Due to the essential nature of the enzyme across 
all bacteria, this is likely true across the Firmicutes.  The gene shows moderate 
sequence conservation overall, with interspersed highly conserved regions to aid 
sequence alignment.  Many structures of the enzyme are also available.  The 
biosynthetic pathway and IPMDH enzyme are also conserved over a large number 
of organisms that can synthesise leucine (Stieglitz & Calvo 1974).   
1.3.1 Biosynthetic Pathway of Leucine  
Branched chain amino acids (leucine, isoleucine and valine) are synthesised using 
a core set of substrates and enzymes (Leavitt & Umbarger 1961; Freundlich et al. 
1962).  The pathway for the synthesis of these three amino acids is illustrated in 
Figure 1.1.   
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Figure 1.1: Biosynthetic pathway of the branched chain amino acids.   
Steps in the biosynthesis of L-valine and L-isoleucine have been omitted for 
clarity.    
 
The synthesis of valine and leucine both proceed from pyruvate, which is 
converted to 3-methyl-2-oxobutanoate via three enzymatically controlled steps.  
The enzymes which act at these reactions also catalyse the early steps in the 
biosynthesis of isoleucine, converting 2-oxobutanoate and pyruvate to (S)-3-
methyl-2-oxopentanoate.  The same transaminase enzyme is also used in the 
biosynthesis of the two amino acids.  From 3-methyl-2-oxobutanoate, valine and 
leucine are synthesised via separate routes.  In the first step specific to the 
synthesis of leucine, 3-methyl-2-oxobutanoate is converted to (2S)-2-
isopropylmalate by 2-isopropylmalate synthase (Calvo et al. 1962).  Successive 
dehydration and addition reactions isomerise isopropylmalate, producing (2R,3S)-
3-isopropylmalate (IPM) via an unsaturated intermediate (Gross et al. 1963). 
Isomerisation is catalysed by the heterodimeric protein isopropylmalate 
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isomerase.  IPMDH catalyses the next oxidation step in the pathway, using NAD
+
 
in the parallel reduction reaction.  The product of this reaction undergoes 
spontaneous decarboxylation, producing 4-methyl-2-oxopentanoate.  
Transamination of this structure produces the product leucine, via the transfer of 
an amine group from L-glutamate (Powell & Morrison 1978).     
1.3.1.1 Regulation of the Pathway  
The pathway to branched chain amino acids is regulated at a variety of points.  As 
the pathway feeds carbon into three different amino acids, tight regulation of the 
pathway is necessary to ensure the correct ratio of the three molecules is made 
relative to the current abundance of each (Singh & Shaner 1995).  Two 
mechanisms to specifically control the rate of leucine biosynthesis have been 
identified in B. subtilis (Ward & Zahler 1973).  2-isopropylmalate synthase 
activity is inhibited by the presence of L-leucine by up to 50 % at pH 7.5.  The 
concentration of the enzymes 2-isopropylmalate synthase, isopropylmalate 
isomerase and IPMDH have also been shown to be decreased in B. subtilis when 
L-leucine is supplied (Ward & Zahler 1973).  Initial enzymes in the process which 
are necessary for the production of all three amino acids in the pathway are only 
repressed when all three amino acids are present in excess (Freundlich et al. 
1962).  This system prevents an excess of any one amino acid inhibiting the 
biosynthesis of another, and specific control over the production of leucine is 
achieved at the steps specific to synthesis of this amino acid.   
1.3.2 Catalysis by Isopropylmalate Dehydrogenase  
IPMDH catalyses the penultimate step in the biosynthesis of leucine, converting 
(2R, 3S)-3-IPM to 4-methyl-2-oxopentanoate in a oxidative decarboxylation 
reaction (Fujita et al. 2001).  The conversion proceeds in a two step process.  
Firstly the substrate is oxidised, in a reaction catalysed by IPMDH.  Analysis of 
products from deuterated substrate have revealed that this reaction proceeds with 
retention of the stereochemistry at C3 (Kakinuma et al. 1989).  Oxidation of is 
IPM is coupled to the reduction of NAD
+
 to NADH.  The (2S)-2-isopropyl-3-
oxosuccinate formed in this reaction undergoes spontaneous decarboxylation to 
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produce 2-oxoisocaproate.  The two steps of this reaction are illustrated in Figure 
1.2. 
 
 
Figure 1.2: Two step reaction catalysed by IPMDH in the biosynthesis of 
leucine.   
 
The activity of IPMDH is dependent on a divalent cation cofactor, typically Mn
2+
 
or Mg
2+
.  Supplementation of reactions with Mn
2+
 results in optimal activity of the 
enzyme (Wallon et al. 1997a).  This divalent metal ion aids the domain closure 
that drives the reaction in conjunction with IPM.  Neither of the components in 
isolation induce a significant closure (0-5 %), and only with both components 
bound is a significant movement induced (Graczer et al. 2011b).  Thus, the metal 
ion appears to be involved in structural movements rather than the actual 
chemistry of the catalysis.  This would also be consistent with kinetic 
observations that NAD
+
 binds before IPM, allowing all components to enter the 
active site prior to domain closure (Pirrung et al. 1994).     
1.3.3 Crystal Structures of Isopropylmalate Dehydrogenase 
Structures of IPMDH from a variety of organisms have been solved using X-ray 
crystallography.  The initial structure from Thermus thermophilus revealed a 
dimeric structure held together by extensive hydrophobic interactions between the 
two subunits, as shown in Figure 1.3.  Each monomer consists of a β sheet 
between two α/β domains, and can be divided into two domains on either side of a 
cleft in the structure.  This structure is homologous to that of isocitrate 
dehydrogenase (ICD), but not to any other known structures.  A hydrophobic 
pocket situated between the two domains includes the residues essential for 
substrate binding, consistent with the observed activity of the enzyme (Imada et 
al. 1991).   
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A B 
  
C D 
  
Figure 1.3: Structure of IPMDH from T. Thermophilus (PDB code 1IPD). 
(A) and (B) show the monomeric unit from the front (A) and rotated 90 ° to 
look down the structure (B); (C) shows the structure in the active dimeric 
form.  Monomers are each coloured based on secondary structure.  Active 
sites can be seen in the cleft in each monomer; (D) shows the dimer rotated 
90 ° in the plane of the page.   
 
From this structure, IPMDH structures have been solved from a variety of 
organisms.  Structures with substrate and cofactors bound have also been solved.  
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A summary of the range of IPMDH structures that have been solved from 
bacterial species is provided in Table 1.2.   
 
Table 1.2:  Summary of solved structures for wild type IPMDH from 
bacteria. 
Species Bound 
components 
PDB code Reference 
T. thermophilus  1IPD (Imada et al. 1991) 
 NAD
+
 1HEX (Hurley & Dean 1994) 
 Inhibitor and 
NAD
+
 
2ZTW (Nango et al. 2009) 
 NADH and 
Mn
2+
 
2Y42 (Graczer et al. 2011a) 
 IPM and Mn
2+
 2Y41 (Graczer et al. 2011a) 
 Mn
2+
 2Y40 (Graczer et al. 2011a) 
B. coagulans  1V53  (Tsuchiya et al. 1997)  
A. ferrooxidans IPM 1A05 (Imada et al. 1998) 
S. typhimurium  1CNZ (Wallon et al. 1997b) 
E. coli  1CM7 (Wallon et al. 1997b) 
M. tuberculosis  1W0D (Singh et al. 2005) 
A. thaliana  3R8W (He et al. 2011) 
T. maritima  1VLC - 
S. typhimurium Mn
2+
 1CNZ - 
Bacillus LCA  3U1H (Hobbs et al. 2012) 
 
1.3.3.1 NAD+ Binding Pocket  
NAD
+
 binds into IPMDH  near where IPM also associates with the structure, so 
that the two units are about 3.5 Å apart by edge to edge distances (Graczer et al. 
2011a).  The structure from T. thermophilus with NAD
+
 bound (Hurley & Dean 
1994) shows that NAD
+
 is in an extended conformation, and the nicotinamide ring 
arranges in both syn and anti conformations.  Interactions between IPMDH and 
NAD
+
 form predominantly through the adenine moiety (see Figure 1.4).  A 
hydrophobic pocket is formed from residues Ile11, Val15, Gly255, Leu254, 
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Ile279 and a portion of Asp326 (residue numbering for the T. thermophilus 
sequence).  Hydrogen bonds are also formed between N2 and N6 and the main 
chain backbone at 286.  The ribose sugar of the adenine moiety forms two 
hydrogen bonds to Asp278; Asp78 forms similar hydrogen bonds to the ribose at 
the nicotinamide end of the structure.  This interaction is likely a major influence 
on cofactor specificity.  Additional interactions to the nicotinamide ring (through 
Glu87) and the phosphate group hydrogen to main chain amide groups at residues 
274 and 276 are present.    
 
              
Figure 1.4: Interactions between NAD
+
 and IPMDH.  Depiction shows the 
syn conformation for the nicotinamide ring only.  Hydrogen bonds are shown 
as dotted lines.  Image taken from Hurley & Dean (1994). 
 
Compared to structures without NAD
+
 bound (Imada et al. 1991), this structure 
adopts a partially closed conformation.   Domain closure is mainly affected by the 
binding of Mn
2+
 and IPM, with influences also from NAD
+
 (Graczer et al. 2011b; 
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Graczer et al. 2011a).  Binding of the adenine moiety to residues from four 
different regions of the enzyme appears to be the driving force behind this partial 
domain closure.  These four binding segments are pulled inwards to form the 
hydrophobic binding pocket, closing the structure around the bound NAD
+ 
(Hurley & Dean 1994).  Domain closure is only fully complete when in the 
dimeric form with IPM also bound, where the loop from one subunit is inserted 
into the cavity between the two domains of the other subunit, extending the extent 
of the hydrophobic interactions (Graczer et al. 2011a).   
1.3.3.2 Substrate Binding Pocket 
A structure of IPMDH from Acidothiobacillus ferrooxidans with the substrate 
IPM bound also shows a partial domain closure (Imada et al. 1998).  IPM binds 
into a pocket formed between the two domains of the monomeric unit.  The 
malate backbone of IPM hydrogen bonds to Arg95, Arg105, Arg133, Tyr140, 
Asp246 and Asp250, as well as residues Lys190 and Asp222 from the second 
subunit in the dimer.  Glu88, Leu91 and Leu92 and Val193 from the second 
subunit form a hydrophobic surface into which the isopropyl moiety fits.  The two 
carbons in the side chain of Glu88 contribute to the hydrophobic pocket, 
interacting in the space formed between the fork of the isopropyl group.  The 
terminal carboxyl of the side chain is situated away from the substrate, potentially 
interacting with NAD
+
.  This is consistent with the observed decrease in binding 
of NAD
+
 when Glu88 is mutated (Dean & Dvorak 1995).  This set up of the active 
site also likely aids electron transfer from IPM to NAD
+
 as the two constituents 
are in close proximity to each other.  The catalytically essential divalent cation is 
also in close proximity to the two redox reactants (Graczer et al. 2011a).   
1.3.3.2.1 Substrate Specificity  
IPMDH shows activity towards a range of substrates.  Activity has been measured 
against a variety of (2R,3S)-3-alkylmalates, with hydrogen, methyl, ethyl, iso-
butyl, tert-butyl and iso-pentyl functional groups substituted in place of the C3 
isopropyl group on the malate backbone of the natural substrate (Miyazaki et al. 
1993; Fujita et al. 2001).  Despite the homology of the structure of IPMDH to 
ICD, little to no catalysis of the oxidation of isocitrate is observed (Miyazaki et al. 
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1993).  Given the hydrophobic pocket formed to accommodate the C3 isopropyl 
group in the native substrate, the lack of activity on isocitrate with a C3 carboxyl 
group is expected.  Consistent with this idea, mutation of residues forming the 
hydrophobic pocket to ionisable groups accommodates the binding of isocitrate 
(Dean & Dvorak 1995).  Glu88 has been suggested to be crucial to the activity 
against a variety of alkylmalates.  The flexibility of this side chain allows 
accommodation of a range of hydrophobic C3 side groups into the active site 
(Imada et al. 1998).       
1.3.4 Isopropylmalate Dehydrogenase in ASR Studies 
IPMDH has previously been the subject of an ASR study and reconstructed back 
to the last common ancestor (LCA) of the Bacillus genus which existed 
approximately 950 million years ago [mya; (Hobbs et al. 2012)].  Four time points 
in this ancestry were reconstructed by ML methods and biochemically 
characterised.  The chronogram and biochemical data for the enzymes 
characterised are given in Figure 1.5.  This reconstruction suggested that the 
evolution of IPMDH over the last billion years in the Bacillus lineage has not 
been a linear process.  The Topt of the reconstructed enzymes fluctuated from 
thermophilic to mesophilic, and back to thermophilic over relatively short time 
scales.  The biophysical properties of the ancestral enzymes also suggest that the 
evolution of IPMDH is complex.  Both ANC1 and ANC4 exhibited significantly 
faster substrate turnover rates than extant IPMDHs, being three and seven times 
faster than IPMDH from the contemporary species B. caldovelox (BCVX).  ANC4 
also showed a higher kinetic barrier to unfolding than any of the other enzymes.  
This would suggest that in the evolution of IPMDH, factors other than the 
catalytic rate and stability have been maximised.   
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A 
 
B 
       Enzyme 
 
KM 
(IPM) 
(mM) 
KM 
(NAD+) 
(mM) 
kcat  
(s-1) 
Topt (°C) 
 
ΔGǂ N-U  
(kJ mol-1) 
Tm 
 (°C) 
BPSYC 0.18 0.61 6.5 47 94.9 - 
BSUB 0.65 8.05 48.7 53 95.9 - 
BCVX 1.12 0.81 53.8 69 100.7 61 
ANC1 1.32 0.52 114.8 73 100.9 64.7 
ANC2 0.96 0.93 41.7 49 91.9 47.6 
ANC3 2.65 0.93 102.3 60 95.6 55.5 
ANC4 1.69 0.97 362.2 70 110.8 65.3 
  
Figure 1.5: Characterisation of ancestral IPMDH from Bacillus.   
(A) ML chronogram based on IPMDH protein sequences.  Ancestral enzymes 
are indicated at nodes.  Bootstrap values for 1024 replicates are also 
indicated.  Contemporary species are coloured based on optimal growth 
temperature [60-80°C (red), 45-50°C (orange), 37°C (yellow), 25-30°C 
(green), 20°C (blue)]; (B) physical constants for contemporary and ancestral 
IPMDH enzymes.  BPSYC (B. psychrosaccharolyticus), BSUB (B. subtilis), 
BCVX (B. caldovelox).   
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1.3.5 Evolutionary History and Promiscuity 
 The closest known paralogues to IPMDH are the NAD-dependent and NADP-
dependent ICD.  These enzymes share the same fold and catalytic mechanism 
(Imada et al. 1998; Chen & Jeong 2000).  Differences in the substrate of these 
enzymes occur at the 2R position of the malate backbone.  This difference is 
evident in the crystal structures of both enzymes, which share largely similar 
substrate binding pockets except in the section accommodating the 2R moiety 
(Imada et al. 1998).  It has been proposed that the ancestral enzyme of these 
paralogues possessed a broad specificity, with activity against a range of 
structurally similar molecules.  Duplication, likely in the progenitor of all extant 
organisms, and diversification of this gene then lead to the paralogues present 
today (Dean & Golding 1997; Chen & Jeong 2000).  Tartrate dehydrogenase also 
belongs to this enzyme family (Tipton & Beecher 1994).    
 
Contemporary IPMDHs show promiscuous activity against a range of (2R, 3S)-3-
alkylmalates.  IPMDH shows activity against structures with a 2R hydrogen 
(malate), methyl, ethyl, iso-butyl, tert-butyl and iso-pentyl moieties on the malate 
backbone.  By comparison, activity is not seen against the alkylmalate isocitrate 
(Miyazaki et al. 1993; Matsunami et al. 1998; Fujita et al. 2001).   Given the 
substrate binding pocket and the charged 2R moiety of isocitrate, this lack of 
activity is expected.  Tartrate, with a 2R carboxyl group, is also an alkylmalate.  
Activity against the (2R, 3S)-3-alkylmalates has been shown to be malleable, 
showing significant changes in rate against the different substrates with single 
amino acid changes near the active site (Fujita et al. 2001).   
1.4 Research Objectives  
IPMDH has previously been reconstructed back to the LCA of Bacillus, giving 
insight into the last billion years of the enzymes’ evolution (Hobbs et al. 2012).  
The limitations of ASR techniques in terms of time and sequence divergence for 
reconstructions of longer time periods than this are unknown with such a large 
and complex enzyme as IPMDH.  This project aimed to take the reconstruction of 
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IPMDH back further to the LCA of the Firmicutes, and test the capability of ASR 
techniques over this time scale.   
 
The reconstruction by Hobbs et al. (2012) indicated interesting trends in the 
evolution of IPMDH with respect to the kinetic barrier to unfolding and catalytic 
rate.  Ancestral enzymes showed faster catalytic rates and more kinetic stability 
than extant counterparts.  This trend raises questions about why ancestral IPMDH 
enzymes have been superseded by slower and less stable counterparts.   A second 
aim was to assess ancestral enzymes in vivo to gauge what impact these enzymes 
have on growth while functioning within the biosynthetic pathway for leucine in a 
cellular context, and assess the fitness of each enzyme.  Substrate promiscuity of 
the contemporary and ancestral enzymes was also assessed, and used to test the 
hypothesis that ancestral enzymes exhibited broader activity which has been 
narrowed down to more efficient specific activity over evolutionary time. 
 
The structure of ANC4, the LCA of the Bacillus has previously been solved, 
revealing structural homology to contemporary thermophilic IPMDH enzymes.  
The final aim of this project was to solve the structure of ANC1 to allow 
structural comparison to ANC4, as well as to contemporary enzymes.  
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2 Materials and Methods 
Additional information on bacterial strains, plasmids, and the compositions of 
reagents, buffers and growth media are given in the appendices. 
2.1 Phylogenetics and Ancestral Inference  
2.1.1 Sequences and Alignment  
All amino acid and nucleotide sequences were obtained from the GenBank data 
base.  Gene accession numbers and species information are available in Appendix 
B1. 
 
IPMDH sequences were collected in a BLAST (Altschul et al. 1990) search 
against the BCVX protein sequence.  Sequences were collated in Geneious 
version 6.1.5 (Drummond et al. 2011) and aligned using the ClustalW2 package 
(Larkin et al. 2007).  The protein alignment was manually checked, and the 
nucleotide sequence edited to match the protein alignment.  Amino acid and 
nucleotide sequence alignments were exported in PHYLIP format.    
2.1.2 Phylogenetic Analysis  
2.1.2.1 Determination of Included Species 
For each genus within the Firmicutes phylum, available sequences were collected 
from GenBank and aligned using ClustalW2 (Larkin et al. 2007).  GARLI version 
1.0 (Zwickl 2006) was used to construct a maximum likelihood tree for each 
genus.  A species representing each deep rooted node of these trees was 
represented in the final tree used for ancestral inference.   
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2.1.2.2 Determination of the Models of Evolution 
ProtTest version 2.4 (Abascal et al. 2005) was used to establish the appropriate 
model of protein evolution for the IPMDH protein alignment.  For the nucleotide 
alignment, jModelTest version 0.1.1 (Posada 2008) was used to determine the 
appropriate model of nucleotide evolution.    
2.1.2.3 Phylogenetic Tree Construction and Validation   
The final protein sequence alignment of the Firmicutes and two Mycobacterium 
out-group species, along with the appropriate model of protein evolution were 
implemented in GARLI version 1.0 (Zwickl 2006) to produce eight maximum 
likelihood trees.  These trees were viewed and rooted in Geneious version 6.1.5 
(Drummond et al. 2011).  The best tree from this set was chosen based on the log 
likelihood values for each tree and overall consistency of clades between the eight 
replicates. 
 
Bootstrapping was performed by running GARLI version 1.0 (Zwickl 2006) to 
construct 1024 pseudoreplicate trees.  This set of trees was opened in Geneious 
version 6.1.5 (Drummond et al. 2011) and a consensus tree generated.     
2.1.3 Ancestral Sequence Inference 
The best tree as determined in section 2.1.2.3 was exported from Geneious 
version 6.1.5 (Drummond et al. 2011) in Nexus format, manually edited into 
Newick format and saved as a .tre file.  Amino acid and nucleotide alignments 
were exported in PHYLIP format and saved as .aa and .nuc files respectively.   
 
Three ancestral inference methods (nucleotide, amino acid and codon) were 
performed in PAML version 4.3 (Yang 2007).  For the nucleotide inference the 
best tree and nucleotide alignment were used in the program BASEML, along 
with the best model of nucleotide evolution as determined by jModelTest 
[(Posada 2008); Section 2.1.2.2].  CODEML was used for the codon and amino 
acid inferences, with the nucleotide and protein alignments respectively, along 
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with the tree and best model of protein evolution as determined by ProtTest 
[(Abascal et al. 2005); section 2.1.2.2]. 
2.1.3.1 Consensus Ancestral Sequence Determination  
The tree description contained within the output rst files from the reconstructions 
were saved as .tre files and visualised in TreeView version 1.6.6 (Page 1996).  
Node labelling from these trees was used to extract the corresponding node 
sequences from the three inferences rst output files.  The inferred sequences from 
the three methods were transferred to Geneious version 6.1.5 (Drummond et al. 
2011), and the nucleotide inference translated into a protein sequence.  The three 
ancestral amino acid sequences for the node of interest were aligned using 
ClustalW2 (Larkin et al. 2007).  A consensus sequence was compiled based on the 
following criteria: if all three methods chose the same amino acid, this amino acid 
was used; if the codon method and one other method chose the same amino acid, 
this amino acid was used.  Any ambiguous sites which did not fit these criteria 
were manually resolved upon examination of the protein alignment based on the 
following criteria: if one of the inferred amino acids was spread evenly over 
contemporary species in the tree, this amino acid was generally chosen; based on 
the JTT model of amino acid classification (Taylor & Jones 1993), amino acids 
with conserved physiochemical characteristics over contemporary species were 
chosen; if the nucleotide and amino acid inferences predicted the same amino 
acid, this amino acid was generally chosen after considering the first two criteria.  
At ambiguous sites, sequence bias from contemporary species branching close to 
the node was also avoided.   
2.2 Cloning  
2.2.1 Gene Synthesis 
The ancestral gene (LCA) was optimised for expression in E. coli and synthesised 
by GENEART (Regensburg, Germany), flanked by the restriction sites XhoI and 
PstI in pMA-T plasmid. 
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2.2.2 Plasmid Extraction  
pPROEX HTb plasmid (Invitrogen, USA) was isolated from DH5α cells grown 
overnight at 37 °C in 5 ml cultures of LB with 100 µg/ml ampicillin (AMP).  
Plasmid was isolated from cells using a QIAprep Spin Miniprep Kit (Qiagen, 
Netherlands) according to the manufacturer’s protocols.   
2.2.3 Plasmid Preparation 
The GENEART plasmid containing the LCA gene was resuspended in 25 µL MQ 
H2O.  A 15 μl aliquot of suspended plasmid was digested with 1 μl each of XhoI 
and PstI and 2 μl of Buffer K (Invitrogen, USA), made up to 20 μl with MQ H2O.  
Digestions were incubated at 37 °C for 3 hours. 
 
Extracted pPROEX (section 2.2.2) was also digested, with adjusted volumes of 25 
μl plasmid, 1.5 μl XhoI and PstI and 3.3 μl Buffer K (Invitrogen, USA), made up 
to 33 μl with H2O.  
2.2.3.1 Agarose Gel Electrophoresis 
Agarose gels (1 % w/v) were made up in TAE buffer (Appendix C1) and 
contained 2-5 µL SYBR safe DNA gel stain (Invitrogen, USA).  DNA samples 
were mixed with 10 x loading dye (Invitrogen, USA) prior to loading.  Gels were 
run at 100V for 40 minutes to achieve DNA separation.  Gels were visualised on a 
blue light box and DNA size determined against a 1 kb plus DNA ladder 
(Invitrogen, USA). 
2.2.3.2 Purification of Digested pPROEX and LCA 
The excised LCA gene was separated from the plasmid fragment by agarose gel 
electrophoresis (section 2.2.3.1).  The band corresponding to the gene was 
carefully excised from the gel with a scalpel and the DNA was extracted using the 
QIAquick Gel Extraction Kit (Qiagen, Netherlands).  Digested pPROEX was 
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purified from solution using the QIAquick PCR purification kit (Qiagen, 
Netherlands).    
2.2.3.3 DNA Quantification 
DNA concentrations were measured via absorbance at 260 nm using a Nanodrop 
ND-2000 spectrophotometer (Nanodrop Technologies, USA). 
2.2.3.4 Ligation 
The ligation of the LCA gene into pPROEX was set up using a 3:1 molar ratio of 
insert to vector based on the measured concentrations of the respective solutions 
(section 2.2.3.3).  The reaction mixture also consisted of T4 ligase and buffer 
(Invitrogen, USA), as per the manufacturer’s instructions.  The reaction was 
incubated at room temperature for 6 hours. 
 
A negative control ligation was also set up with the same composition, minus the 
gene insert.  This control was treated the same throughout the ligation and 
transformation steps of the protocol.  
2.2.4 Transformation 
2.2.4.1 Electrocompetent Cell Preparation 
Starter cultures were set up in 10 ml of LB in a 50 ml Falcon tube, inoculated with 
a single colony of cells plated from glycerol stocks and incubated at 37 °C 
overnight with shaking.  The 10 ml overnight starter culture was used to inoculate 
1 L of LB in a 2 L baffled flask.  Cells were incubated at 37 °C with shaking at 
200 rpm until log phase was reached [an OD600 between 0.5 and 0.7 as measured 
by a Heλios spectrophotometer (Thermo Scientific, USA)].  Once an appropriate 
optical density (OD) was reached, the flask was chilled on ice for 30 minutes then 
the culture transferred to sterile centrifuge bottles and cells isolated by 
centrifugation at 4,600 rpm for 15 minutes at 4 °C.  The supernatant was removed, 
and the cell pellet resuspended in a total of 1 L cold, sterilised 10% glycerol, and 
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then centrifuged as before.  This centrifugation and resuspension process was 
repeated in sequentially decreasing volumes of ice-cold sterile 
10% glycerol (0.5 L, 20 ml, and 2.5 ml).  Aliquots of 50 µL from the final 2.5 ml 
resuspension were transferred to individual tubes and immediately frozen for 
storage at -80 °C. 
2.2.4.2 Electroporation 
Plasmids were transformed into electrocompetent DH5α cells using the Bio-Rad 
Gene Pulser (Bio-Rad Laboratories, USA).  Chilled electro-cuvettes (Bio-Rad 
Laboratories, USA) were filled with 10 μl of plasmid, 50 μl of thawed 
electrocompetent DH5α cells and 30 μL of 10 % glycerol, and electroporated with 
2.5 kV at 25 µF capacitance and 200 Ω resistance.  Immediately after 
electroporation, 1ml of LB was added to the cells.  Cells were left at 37 °C for 1 
hour to recover.   
2.2.4.3 Transformant Selection 
After recovery, 100 µL of transformation cell suspension was plated on LB agar 
plates containing 100 µg/ml AMP.  The remainder of the cells were pelleted by 
centrifugation (13,000 rpm, 3 minutes) and streaked onto LB agar plates 
containing 100 µg/ml AMP.  Plates were incubated overnight at 37 °C, and the 
number of colonies compared between the control and ligation plate.     
2.2.4.4 Gene Insert Screening  
Four colonies were selected and grown in 5 ml LB containing 100 µg/ml AMP 
overnight with shaking at 37 °C.  Colonies were checked for the presence of insert 
by purifying the plasmid from 3 ml of the overnight culture as described in section 
2.2.3.2.  Plasmids were then digested as described in 2.2.3, and the resultant 
fragments run on an agarose gel as described in 2.2.3.1.   
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2.2.4.5 Glycerol Stocks 
A culture with a positive screen for the LCA insert was then used to make up a 
glycerol stock.  Glycerol stocks were made of 900 µL of overnight culture with 
100 µL of sterile 80 % glycerol.  Glycerol stocks were frozen and stored at -80 
°C.  
2.3 In vitro Enzyme Characterisation 
2.3.1 Protein Expression 
Cell starter cultures were grown from glycerol stocks in 10 ml LB cultures with 
100 µg/ml AMP overnight at 37 °C.  Starter cultures were used to inoculate 1 L of 
TB with 100 µg/ml AMP in a 2 L baffled flask, and grown at 37 °C while shaking 
at 200 rpm.  OD was measured at various intervals at 600 nm using a 
ThermoSpectronic Heλios spectrophotometer (Thermo Scientific, USA) till log 
phase was reached (OD from 0.5 to 0.7).  Once in log phase, protein expression 
was induced with the addition of IPTG to a final concentration of 1 mM, and 
expressed overnight at either 37 °C or 18 °C.  Cells were isolated by 
centrifugation (4600 rpm, 15 minutes, 4 °C) and stored at -80 °C. 
2.3.2 Protein Purification 
2.3.2.1 Cell Lysis 
Cells were resuspended in 30 ml of lysis buffer (50 mM sodium phosphate buffer, 
pH 8.0, 300 mM NaCl, and 50 mM imidazole) and sonicated on ice for six 15 
second intervals separated by 30 second cooling periods.  Cell debris was 
removed by centrifugation at 15,000 rpm at 4 °C for 20 minutes.   
2.3.2.2 Immobilised Metal Affinity Chromatography Purification  
HisTrap (GE Healthcare, UK) nickel columns were prepared before use by 
passing 2 column volumes of 100 mM EDTA pH 7.5 to remove Ni
2+
 ions, and 
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recharged with 1 column volume of 100 mM NiCl2.  Washing with 2 column 
volumes of H2O followed the Ni
2+
 removal and recharging steps.  The column 
was equilibrated with lysis buffer prior to use.   
 
Supernatant from the sonication process was passed in succession through 1.2 μm, 
0.45 μm, and 0.2 μm filters before loading onto a prepared 5 ml HisTrap FF nickel 
affinity column (GE Healthcare, UK) for immobilised metal affinity 
chromatography (IMAC) purification.  Filtered supernatant was loaded onto a 
prepared nickel column equilibrated with two column volumes of lysis buffer.    
 
Bound protein was eluted from the nickel column on an ÄKTA Basic, Prime, or 
Purifier system (GE Healthcare, Sweden).  Protein bound with low affinity was 
removed via washing at 1 ml per minute with a solution of 4 % elution buffer (50 
mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, and 1 M imidazole) until 
the 280 nm absorbance dropped to baseline and levelled off.  A gradient from  
0-100% elution buffer at a rate of 1 ml per minute over 50 ml was used to elute 
the target protein from the column and collected as 2 ml fractions.  
2.3.2.3 Size Exclusion Purification 
2.3.2.3.1 Standard Protocol  
Pooled nickel fractions with desired protein present as identified by SDS-PAGE 
(section 2.3.2.6) were pooled and concentrated (section 2.3.2.4) down to 20 
mg/ml (measured as described in section 2.3.2.5).  Concentrated protein was 
passed through a 0.2 µm filter and loaded onto a Superdex 200 10/300 GL column 
(GE Healthcare Life Science, UK) equilibrated with size exclusion (SE) buffer 
(20 mM potassium phosphate buffer, pH 7.6).  Protein was eluted by flowing 
elution buffer at 0.5 ml/minute through the column, with fractionated collection in 
0.5 ml aliquots.  Protein elution was followed by absorbance measurement at 280 
nm, and fractions identified as containing protein from these measures further 
assessed by SDS-PAGE (Appendix C3).  Protein containing fractions were pooled 
and concentrated to the necessary concentration for further use.   
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2.3.2.3.2 Reductant Based Protocol 
When disulfide bridges were potentially an issue in protein folding, SE buffer was 
supplemented with 1 mM of the reductant β-mercaptoethanol.   
β-mercaptoethanol to a final concentration of 1 mM was also added to the protein 
prior to loading onto the column. 
2.3.2.4 Protein Concentration  
Proteins were concentrated by centrifugation in 0.5 ml, 2 ml, or 20 ml Vivaspin 
concentrators with a 10 kDa cut off (Sartorius AG, Germany) at 4000 rpm at 4 °C. 
2.3.2.5 Protein Concentration Measurement 
Protein concentration was measured using a Nanodrop 2000 UV-vis 
spectrophotometer (Thermo scientific, USA) and the extinction coefficient 
calculated by ProtParam (http://web.expasy.org/protparam/)   
2.3.2.6 SDS-PAGE Gels 
Protein samples were mixed with 4 x loading buffer and incubated at 95 °C for 
five minutes.  Aliquots of 15 µL were loaded into wells of 12 % SDS gels (see 
Appendix C3), along with 10 µL of Precision Plus Protein Unstained Ladder (Bio-
Rad Laboratories, USA).  Gels were run at 15 mA through the stacker layer, and 
at 30 mA through the rest of the gel until the dye front reached the end of the gel. 
 
For staining, gels were transferred to microwavable containers, covered with 
coomassie stain (Appendix C1) and microwave heated for 30 seconds.  Gels were 
left at room temperature with shaking for 10 to 20 minutes to complete dyeing.  
Coomassie stain was decanted off, the gel covered in destain solution (10 % v/v 
acetic acid) and microwave heated for 30 seconds and shaken at room temperature 
for at least half an hour.  Destaining steps were repeated till protein bands were 
well defined.      
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2.3.3 Enzyme Assays 
Assays were conducted in a ThermoSpectronic Heλios spectrophotometer 
(Thermo Scientific, USA), with a single cell peltier-effect cuvette holder to 
control reaction temperatures.  Absorbance values at 340nm were taken at 0.25 
second intervals over a reaction time of one minute to follow the reaction through 
the formation of the cofactor reduction product, NADH (Hobbs et al. 2012).   
 
Substrates were made up as stock solutions in assay buffer (20 mM potassium 
phosphate buffer, pH 7.6, 300 mM KCl and 0.2 mM MnCl2).  The cofactor, 
NAD
+
, was made up as an 80 mM stock solution in MQ H20.  The substrate was 
diluted to the desired concentration in assay buffer, and 350 µL of was heated in 
the cuvette to the desired temperature before the addition of 50 µL of NAD
+
 (10 
mM final concentration) and reheated to the reaction temperature.  Reactions were 
started by the addition of 2 μl of enzyme in SE buffer, rapidly mixed, and the 
course of the reaction followed for the following minute. 
2.3.3.1 Michaelis-Menten Kinetic Analysis 
Michaelis-Menten kinetics were measured at the Topt of each enzyme.  The 
reaction rate was measured at a variety of substrate concentrations, with an excess 
concentration of the cofactor NAD
+
 (10 mM).  Details of the reaction protocol are 
given in section 2.3.3.  The initial rate for each reaction was manually assessed 
from the resultant plots of time versus absorbance at 340 nm. 
 
Graphpad Prism version 5.01 (GraphPad Software, USA) was used to fit 
Michaelis-Menten plots to the data and determine KM and Vmax values.  To 
calculate kcat, abs/s at Vmax was converted to conc/s using the Beer-Lambert Law 
and molar absorptivity of NADH (6,220 L
 
M
−1 
cm
−1
).  The increase in molar 
concentration of NADH was divided by the molar concentration of enzyme added 
to the reaction to determine the kcat of the reaction.    
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2.3.3.2 Specific Activity Analysis 
The specific activity of enzymes was measured as described in section 2.3.3 at the 
Topt for each enzyme.  Substrate concentration was kept constant over replicates 
and different enzymes.  Reaction rates in abs/s were converted to  
mM product/s/mM protein based on the absorbance change and concentration of 
enzyme used.  
2.4 In vivo Enzyme Characterisation 
2.4.1 Cell Strains 
E. coli K-12 BW25113 single gene knockout strains of the genes leuB, icd, mdh 
and yeaU (IPMDH, ICD, malate dehydrogenase and tartrate dehydrogenase 
respectively), as well as the parent strain, were obtained from the Keio collection 
(Baba et al. 2006).   
 
Cells were made electrocompetent and transformed as described in section 2.2.4.  
Plasmids used in this transformation (pPROEX containing the leuB gene) were 
purified as described in section 2.2.3.2 from DH5α cells previously screened for 
the correct plasmid insert.  The parent strain and each knockout strain were also 
transformed with an empty pPROEX plasmid to act as controls.  A full list of 
transformants used in this study is available in Appendix A2. 
2.4.2 Growth on Solid Media 
Cells were grown at 37 °C with shaking in 1 ml of LB media with 100 µg/ml 
AMP and 30 µg/ml kanamycin (KAN) in 10 ml Falcon tubes.  Parent strains were 
grown under the same conditions, minus the KAN antibiotic.  To remove residual 
LB, cells were pelleted by centrifugation (10 minutes, 4000 rpm, 4 °C) and 
resuspended in 1 ml M9 minimal media supplemented with 100 µg/ml AMP.  
Cells were pelleted and resuspended a second time before plating on M9 agar 
plates containing 100 µg/ml AMP and 1 mM IPTG.  Plates were grown at 37 °C 
for 24 to 36 hours depending on the rate of growth.     
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2.4.2.1 Determination of Carbon Source Utilisation  
Cells were washed and resuspended in M9 media, and streaked out on M9 agar 
plates containing 100 µg/ml AMP, 1 mM IPTG and various carbon sources 
(glucose 10 g/L; malate 2 g/L and 5 g/L; sodium acetate 5 g/L; succinate 5 g/L).  
 
Media appropriate for testing the enzyme activity in vivo was determined by 
growth of the parent strain with empty pPROEX vector, and no growth of the 
knockout strain with empty pPROEX vector.   
2.4.2.2  Semi-quantification of Growth Rate 
Cells were prepared as detailed in section 2.4.2.  Cells were serially diluted to 
concentrations of 1/10, 1/100, 1/1,000 and 1/10,000 in M9 media containing 100 
µg/ml AMP, 1 mM IPTG and the relevant carbon source for each strain.  Each 
dilution plus the undiluted culture were spotted out in 20 µL drops on 100 µg/ml 
M9 agar plates (Juhas et al. 2012).   
2.4.3 Growth Rate Determination  
2.4.3.1 Growth Measurement  
To determine growth rate, cells were grown in liquid M9 media.  Inoculation 
cultures were made up from glycerol stocks in 1 ml of LB supplemented with 100 
µg/ml AMP and 30 µg/ml KAN.  Cultures were grown overnight at 37 °C with 
shaking.  The LB culture was used to inoculate (1 in 100) 1 ml of M9 media, 
supplemented with 100 µg/ml AMP and 30 µg/ml KAN, and grown at 37 °C for 
24 hours; this was repeated into a second M9 starter culture and grown for an 
additional 48 hours.   
 
The final starter culture was used for a 1 in 100 inoculation of 100 µl of M9 media 
containing 100 µg/ml AMP, 1 mM IPTG and 30 µg/ml KAN.  Cells were grown 
in 96 well plates.  Plates were incubated at 37 °C with shaking in a Multiskan GO 
Microplate Spectrophotometer (Thermo Scientific, USA).  OD was measured in 
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20 minutes intervals, at which times shaking was stopped.  Measurements were 
continued for up to 200 measurements.  
2.4.3.2 Analysis of Growth Rates 
Changes in OD over the course of the experiment were plotted as time versus log 
OD graphs.  The slope of the log increase in OD over the section of maximum 
growth rate of these plots was taken as the specific growth rate (Breidt et al. 1994) 
and converted to the doubling time of the culture.     
2.5 Protein Crystallography  
2.5.1 Protein Preparation 
Protein was expressed as in section 2.3.1, and isolated and purified as in section 
2.3.2.  The buffer used for the SE was changed to 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid.  Purified protein was concentrated (section 2.3.2.4) 
to between 50 and 60 mg/ml. 
2.5.2 Initial Crystallisation Condition Determination 
General crystallisation conditions were determined by the sitting drop method.  
From the four crystallisation screens PEGRx HT - HR2-086, Crystal Screen HT - 
HR2-130, Index HT - HR2-134, and SaltRx HT - HR2-136 (Hampton Research, 
USA) 100 μL of each precipitant solution (96 per crystallisation screen) were 
pipetted into the large wells of four 96-2 low profile Intelli-Plate protein 
crystallisation plates (Hampton Research, USA).  A Mosquito crystallisation robot 
(TTP LabTech Ltd., USA) was used to lay each screen, dispensing 100 nL of 
protein and 100 nL of mother liquor into the sitting drop wells of the Intelli-
Plates.  Plates were sealed with ClearSeal film (Hampton Research, USA) and left 
at 18 °C on shock proof shelving.  Conditions were checked regularly for crystal 
growth.     
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2.5.2.1 Additive Crystallisation Condition Screening 
Sitting drop crystallisation screens were also performed as in section 2.5.2 with 
the addition of cofactors of the reaction to stabilise the protein.  NAD
+
 to a final 
concentration in the drop of 1 mM and MnCl2 to a final concentration of 0.2 mM 
were added to the protein prior to the screens being laid down. 
2.5.3 Fine Screening to Optimise Crystallisation Conditions 
2.5.3.1 Standard Fine Screen 
The hanging drop method was used to screen potential crystallisation conditions 
from the four crystal screens.  Variants of the mother liquor pH and component 
compositions were set up in 24-well VDX plates (Hampton Research, USA).  
Each well top was lined with grease for air tight sealing, and filled with 500 µL of 
mother liquor.  Aliquots of 1 µL of protein solution were pipetted onto a 
siliconised glass cover slip, and mixed with1 µL of the mother liquor by pipetting.  
The cover slip with protein-mother liquor drop was then inverted over the pre-
greased well and gently pressed to seal.  Plates were stored at 18 °C on shock 
proof shelving.  
2.5.3.2 Seeding Screens 
2.5.3.2.1 Batch Seeding 
Batch seeding was performed when crystals were of low quality.  A sacrificial 
drop from a previous fine screen was diluted 10-fold in mother liquor and 
vortexed to produce a stock seeder solution.  This solution was further diluted to 1 
in 100, 1 in 1,000 and 1 in 10,000.  The three lower dilutions were used as the 
mother liquor in the protein droplet over standard mother liquor in hanging drop 
fine screens, as described in section 2.5.3.1.  
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2.5.3.2.2 Streak Seeding 
Streak seeding was performed when crystals were of low quality.  Fine screens 
were set up as described in section 2.5.3.1 and left at 18 °C for four hours.  A cat’s 
whisker was used to streak through a crystal containing droplet from a previous 
fine screen, and streaked through the seeding droplet to transfer crystals.  Plates 
were stored at 18 °C on shock proof shelving.  Whiskers were cleaned with 
ethanol between use. 
2.5.4 Crystal Preparation for Data Collection 
Protein crystals were transferred via a cryo-loop (Hampton research, USA) to a 
cryo- protectant solution of mother liquor containing 20 % v/v glycerol.  Crystals 
were left in this solution for approximately 30 seconds.  Alternately, a series of 
cryo-protectants of increasing glycerol concentration (5%, 10%, 15%, 20%) were 
used to soak the crystal.  Soaked crystals were frozen in liquid or gaseous nitrogen 
depending on the data collection procedure used.  
2.5.5 Crystal Diffraction Testing 
Crystals for X-ray diffraction testing were prepared as described in section 2.5.4, 
mounted in a SuperNova X-ray diffractometer (Agilent, USA) and frozen by a 
stream of gaseous nitrogen at 100 K.  Diffracting crystals were transferred to 
liquid nitrogen for storage and full data collection.  
2.5.6 Data Collection 
X-ray diffraction data were collected at the Australian Synchrotron, Melbourne, 
Australia using the MX1 and MX2 beam lines.  To measure reflections, an ADSC 
Quantum 210r detector (Area Detector Systems Corp., USA) was used.  The 
MOSFLM (Leslie & Powell 2007) strategy function was used in conjunction with 
the collection process to assist optimal data collection.   
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2.5.7 Data Processing 
2.5.7.1 Indexing and Integration  
Diffraction images were visualised, scaled and integrated in MOSFLM (Leslie & 
Powell 2007).  Unit cell parameters were determined through the auto indexing 
function, and integrated in the appropriate space group for the data.  When issues 
were encountered in integration due to low intensity spots at high resolution, a 
resolution cut off was applied prior to indexing.    
2.5.7.2 Combining of Two Data Sets 
Indexed data sets were combined using Sortmtz (P. J. Daly, Daresbury) within the 
CCP4 program suite (Winn et al. 2011).  One data set was renumbered, and added 
onto the first image set so that a continuous series of images was produced.    
2.5.7.3 Scaling 
Data was scaled in SCALA (Evans 2006) within the CCP4 program suite (Winn 
et al. 2011).  SCALA outputs were examined, and the data rescaled at decreasing 
resolution to optimise Rmerge to below 80 % in the outer shell of the data.  
2.5.7.4 Matthews Coefficient 
The number of monomers in the asymmetric unit was calculated from indexed 
output files using MATTHEWS_COEF (Matthews 1968) in CCP4 (Winn et al. 
2011).  The number of monomers in the asymmetric unit was selected based on 
calculated solvent occupancy of the unit cell.   
2.5.7.5 Molecular Replacement 
Molecular replacement was performed using the structure of the LCA IPMDH of 
Bacillus (PDB code 3U1H).  Molecular replacement was performed using 
PHASER (McCoy et al. 2007) within PHENIX (Adams et al. 2010). 
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2.5.7.6 Model Refinement 
Automated refinement of the model was executed in Autobuild (Terwilliger et al. 
2008) within PHENIX (Adams et al. 2010).  Manual building and refinement of 
the model was performed in COOT (Emsley & Cowtan 2004) with electron 
density maps contoured to 1 σ.  Model refinement was performed using 
phenix.refine (Afonine et al. 2012).     
2.5.8 Structural Analysis 
All structures image in this work were generated in PyMOL version 2.5.4 (Delano 
2002).  Ramachandran analysis was performed in Procheck in the CCP4 program 
suite (Winn et al. 2011).  Average B factors were calculated in Baverage in the 
CCP4 program suite.  Structural homologues were determined in PDBeFold 
(Krissinel & Henrick 2004).  PDBePISA (Krissinel & Henrick 2007) was used to 
calculate the buried surface area of the dimer interface.   
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3 Phylogenetics, Ancestral Inference and 
Activity Assessment  
3.1 Introduction 
IPMDH has been the focus of previous ancestral reconstruction studies (Miyazaki 
et al. 2001; Hobbs et al. 2012).  IPMDH is an ideal candidate for ASR as it is 
easily over expressed and biochemical assay protocols are well defined, aiding 
characterisation of the enzyme (Wallon et al. 1997a).  Biochemical 
characterisation of the reconstructed enzymes also acts as a good indicator of a 
successful inference, as inference errors in ancestral sequences are likely to result 
in inactive or biologically unrealistic enzymes.   
 
Previous ASR studies of IPMDH have successfully reconstructed the enzyme 
back 950 million years (myr) to the LCA of Bacillus (Hobbs et al. 2012).  Taking 
ancestral reconstructions back further than this is questionable due to the levels of 
sequence divergence.  The only enzyme that has been reconstructed back past this 
time period is β-lactamase (Risso et al. 2013).  In this case, enzymes from 2–3 bya 
showed biologically realistic thermal denaturation and catalytic rates.  However 
the limitations of ASR in terms of time and sequence divergence are not known 
for such a large and complex enzyme as IPMDH.  Here, the ability for ASR 
techniques to reconstruct IPMDH back to the LCA of the Firmicutes, about 2.7 
bya (Battistuzzi et al. 2004), was assessed.  
3.2 Results and Discussion 
3.2.1 Selection of Representative Species 
In order to perform an ancestral inference, alignments of extant nucleotide and 
amino acid sequences are necessary.  IPMDH sequences for use in these 
alignments were obtained from the GenBank database following a BLAST 
(Altschul et al. 1990) search against the BCVX IPMDH protein sequence.  
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Accession numbers for all the sequences used in this study are given in Appendix 
B1. 
 
A common issue with ASR is determining how many species to include in the 
analysis, and which species should be incorporated to give a good representation 
of overall diversity.  It has been shown that the inclusion of more taxa in a tree is 
not necessarily better for ancestral inference, assuming the tree topology is correct 
(Li et al. 2008).  However, species which accurately represent the range of extant 
diversity must be selected.  To choose sequences which represented the size and 
diversity of each major genus within the Firmicutes as included in the phylogeny 
(Battistuzzi et al. 2004), phylogenetic trees were constructed of each genus 
(Bacillus, Clostridium, Lactococcus, Listeria, Staphylococcus, Streptococcus and 
Thermoanaerobacter).  Mycoplasma and Ureaplasma were unable to be included 
due to the reduction of the genome size which has removed all the amino acid 
biosynthesis genes in these species (Battistuzzi et al. 2004).  Trees were 
constructed in GARLI (Zwickl 2006) from ClustalW (Larkin et al. 2007) protein 
alignments of all species within each genus available from the GenBank database.  
Sequences representing main branches of each tree were selected for inclusion in 
the full Firmicutes tree as described previously (Iwabata et al. 2005).  Trees can 
be found in Figure 3.1.  For the lactococci, all sequences available were identical 
over 99 % of residues.  No tree was constructed in this case.  The Bacillus tree 
illustrated in Figure 3.1 shows similar species groupings to the previously 
described tree for Bacillus IPMDHs (Hobbs et al. 2012).        
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Bacillus tree Clostridium tree 
  
Listeria tree Staphylococcus tree 
  
Streptococcus tree Thermoanaerobacter tree 
Figure 3.1: Phylogenetic trees used for the selection of representative species 
from each major genus of the Firmicutes.   
The scale for substitution rate per site per unit time is indicated at the bottom 
of each tree.  Species selected for inclusion in the final phylogenetic tree are 
indicated with circles.   
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Mycobacterium was selected as the outgroup based on the known phylogenetic 
relationship of this group to the Firmicutes (Battistuzzi et al. 2004).   
 
Representative species of each genus selected for inclusion in the full Firmicutes 
tree and as the outgroup are listed in Table 3.1.   
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Table 3.1: List of species selected for inclusion into the full Firmicutes tree. 
Genus Species 
Bacillus  B. caldovelox 
  B. cereus 
  B. cytotoxicus 
  B. halodurans 
  B. megaterium 
  B. psychrophilus 
  B. subtilis 
Clostridia C. acetobutylicum 
  C. clariflavum 
  C. clostridioforme 
  C. leptum  
   C. ljungdahlii  
  C. papyrosolvens  
  C. ramosum   
Lactococcus L. lactis  
Listeria L. grayi 
  L. monocytogenes 
  L. seeligeri serovar  
Staphylococcus Staph. aureus 
  Staph. capitis  
  Staph. hominis 
  Staph. lugdunensis 
  Staph. pettenkoferi  
Streptococcus Strep. cristatus  
  Strep. downei  
  Strep. equinus  
  Strep. mutans   
  Strep. pneumoniae  
  Strep. suis  
  Strep. thermophilus  
Thermoanaerobacter T. tengcongensis  
  T. wiegelii  
  T. xylanolyticum 
Mycobacteria  (outgroup) M. tuberculosis 
  M. leprae 
 
3.2.2 Sequence Alignment  
In order to construct a phylogenetic tree of the representative Firmicutes 
sequences, alignments of the nucleotide and amino acid sequences must be made  
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to match equivalent codons/amino acids from each sequence.  Alignment was 
performed in ClustalW (Larkin et al. 2007) and manually checked and adjusted.  
Overall alignment was aided by highly conserved regions dispersed throughout 
the gene (see Figure 3.2).  A number of these conserved regions correspond to the 
substrate binding domain in the crystal structure (Imada et al. 1998).  For 
example, Arg102, Arg112, Arg141, Tyr148, Lys200, Asp233, Asp257 and 
Asp261 (numbering corresponding to the sequence alignment in Figure 3.2) bind 
to the malate backbone of IPM, and are universally conserved over all known 
IPMDHs.  Universally conserved residues Glu95, Leu98, Leu99 and Val203 make 
up the binding pocket for the isopropyl group of the substrate.  Residues in the 
NAD
+
 binding pocket are also conserved over most species in the alignment, with 
the more variable sites showing conservation of hydrophobic amino acids.  These 
residues include the universally conserved Asp346, and highly conserved Ile15, 
Val19, Leu270, Gly271 and Ile298 (Hurley & Dean 1994).  Gaps between these 
conserved regions were edited manually to resolve any obvious errors in the 
alignment.  Overall the protein alignment seen in Figure 3.2 has 52.6 % pairwise 
identity and 13.6 % identical sites.  The percentage of identical sites in the 
alignment is low, likely due to the range of species included in the alignment. 
However, the pairwise identity of the alignment is considerably higher than the 
percentage of identical sites.  Areas with lower conservation over the alignment 
fulfil structural functions rather than having direct involvement in the chemistry 
of catalysis.   
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Figure 3.2: Firmicutes IMPDH protein sequence alignment.   
Alignment was generated with ClustalW (Larkin et al. 2007) in Geneious 
(Drummond et al. 2011).  Shading at each position indicates the percentage 
similarity based on residue chemistry of the position over the sequence 
alignment.  Black = 100 %; dark grey = 80-100 %; light gray = 60-80 %; 
white = < 60 % similarity.   
Phylogenetics, Ancestral Inference and Activity Assessment                                              
49 
 
3.2.3 Phylogenetic Analysis  
For the IPMDH amino acid alignment, the most appropriate model of evolution to 
describe the rate at which one amino acid replaces another was determined in 
ProtTest (Abascal et al. 2005).  The LG model of evolution (Le & Gascuel 2008) 
was found to model the data the most accurately under both Akaike information 
criterion (AIC) and Bayesian information criterion.  The model with the lowest 
AIC score represents the best model out of those available based on the relative 
likelihood.  The LG model incorporates varying rates of evolution across sites in 
the matrix, and is considered to be the most sophisticated without being overly 
computationally demanding (Le & Gascuel 2008). 
 
The LG model and alignment shown in Figure 3.2 were used in GARLI (Zwickl 
2006) as described in section 2.1.2.3 to produce eight ML trees.  The phylogenetic 
trees were rooted manually by selecting the two Mycobacterium species as the 
outgroup.  Log likelihood scores (-ln) and a manual assessment of the correct 
association of species into genus groups was used to assess the best tree.  A tree 
with a -ln of -13565 was selected, as shown in Figure 3.3.  Despite other trees 
having slightly better -ln scores, this tree was selected due to the consistent 
association of species into the correct genera.  Two inconsistencies in genera 
groupings are evident: L. lactis is grouping with the streptococci, and  
C. ljungdahlii is separate from the rest of the clostridia, separated by the 
Thermoanaerobacter.  These discrepancies occurred consistently in all the tree 
replicates performed.  L. lactis is closely related to the streptococci, and shares 
many similar features (Schleifer et al. 1985).  Clostridia and Thermoanaerobacter 
are also closely related (Collins et al. 1994a; Battistuzzi et al. 2004).  Thus, the 
grouping of these sequences together is not surprising.   
 
Confidence in the phylogeny was assessed by bootstrapping (Felsenstein 1985; 
Efron et al. 1996).  1024 pseudoreplicate trees were generated in GARLI (Zwickl 
2006) and combined into a consensus tree where bootstrap values are assigned to 
branches based on the proportion of pseudoreplicate trees including the node.  
This number allows the reliability of each node within the tree to be estimated.  
Bootstrap values are included on branches in the phylogenetic tree in Figure 3.3. 
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Figure 3.3: ML phylogeny of the Firmicutes based on IPMDH amino acid 
sequences.    
The position of the reconstructed LCA of the Firmicutes is indicated as a 
black circle.  LCA is about 2.7 billion years old (Battistuzzi et al. 2004).  
Numbers on branches represent bootstrap percentages.  The scale for 
substitution rate per site per unit time is indicated at the bottom of the tree.    
3.2.4 Ancestral Inference  
ML was chosen to perform this analysis as previous inference of ancestral 
IPMDH enzymes by BI methods produced biochemically unrealistic enzymes.  
By comparison, ML methods produced ancestral IPMDHs with realistic 
functional parameters (Hobbs et al. 2012). 
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Inference on the basis of nucleotides and codons requires a nucleotide alignment 
that matches the amino acid alignment and an appropriate model of nucleotide 
evolution.  The most appropriate model of nucleotide evolution for the alignment 
was determined by jModelTest version 0.1.1 (Posada 2008) to be the generalised 
time reversible model (Tavaré 1986).  This model assumes a symmetric 
substitution matrix for complementary base pairs (bp), different rates of 
substitution for each nucleotide pair, and allows nucleotides to occur at different 
frequencies.   
 
Nucleotide, amino acid and codon ancestral inferences were performed in PAML 
version 4.3 (Yang 2007).  Average posterior probabilities for each of these 
inferences for the LCA of the Firmicutes were 0.842 (amino acid), 0.815 
(nucleotide) and 0.693 (codon).  Probabilities are calculated from the likelihood of 
each amino acid or nucleotide occupying a particular site given the data and 
evolutionary model.  These probabilities are slightly lower than ideal for an 
ancestral reconstruction (greater than 0.9), but not unexpected given the timescale 
of the inference and were deemed sufficient to continue with the process.  Inferred 
nucleotide and codon sequences for the LCA of the Firmicutes were translated to 
amino acid sequences, and all three inferences were aligned using ClustalW 
(Larkin et al. 2007).  A consensus sequence was complied and any ambiguous 
sites resolved under the criteria listed in section 2.1.3.1.  There were few 
ambiguous sites in the ancestral sequence, with only 22 ambiguous residues out of 
the 382 amino acid alignment not agreeing under all three inference methods, or 
the codon plus one other inference method.  Of these, 13 were resolved by 
selecting the amino acid for which the nucleotide and amino acid reconstructions 
both agreed.  Ambiguous sites were generally in regions of the alignment that 
showed high levels of sequence divergence, and often potential residues at an 
uncertain site were chemically similar.  The C terminal end of the sequence was 
also truncated by 10 residues compared to the total alignment as this end region is 
only present in the Bacillus species of the alignment, and likely represents an 
insertion present only in this genus.  In the B. coagulans structure (PDB code 
1V53), these 10 C terminal residues are not resolved, and likely represent a 
Phylogenetics, Ancestral Inference and Activity Assessment                                              
52 
 
flexible region of the enzyme not essential of catalysis.  The final sequence for the 
LCA of the Firmicutes is given below.   
 
IPMDH sequence of the LCA of the Firmicutes  
MKMKIAVIPGDGIGPEIIEEAIKVLNAVAEKYGLKFEYKEVLLGGCAIDETGVPL
PEETVEVCKKSDAVLLGAVGGPKWDNLPSNKRPEAGLLGIRKGLGVYANLRPAIL
YPALKSASPLKPEILEGIDIMVVRELTGGIYFGERGRIDIGGKKAYDTEIYTTFE
IERIARKAFEAARKRNKKLTSVDKANVLESSRLWREVVEEVAKEYPDVELNYMYV
DNASMQLIRDPKQFDVIVTSNMFGDILTDEASMLTGSIGMLPSASLRGDGPSLYE
PVHGSAPDIAGQNKANPIATIMSVAMMLKYSFDMEEAADDIKNAVEKVLEEGYRT
GDIAIEGTKIVGTEEMGDLIVEDLEKI 
 
Comparison of the inferred ancestral sequence (see Table 3.2) to contemporary 
proteins gives pairwise identities between 47% and 80 % (identity to  
S. pettenkoferi and C. ljungdahlii respectively).  These numbers are not so closely 
related to any one species to suggest that an extant sequence may be overly 
biasing the ancestral node: this is particularly significant for deep branching 
species such as C. ljungdahlii.  The extant and ancestral sequences are also all 
reasonably related, indicating a degree of structural and functional conservation, 
thus increasing the likelihood of a successful reconstruction.  Pairwise identities to 
M. leprae and M. tuberculosis are low (40 % and 43 % respectively), consistent 
with these groups relatedness to the rest of the tree.  Sequences from the clostridia 
and Thermoanaerobacter show the highest sequence similarity to the LCA, 
consistent with the deep branching position of these species in the tree.  
 
Following inference, the gene encoding the LCA sequence was synthesised by 
GENEART (Regensburg, Germany).  The gene sequence is provided in Appendix 
B2. 
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Table 3.2: Comparison of the pairwise sequence identities between extant and ancestral protein sequences.  
 
Abbreviations: Ancestor (ANC), B. caldovelox (BCVX), B. cereus (BCER), B. cytotoxicus (BCYT), B. halodurans (BHAL), B. megaterium (BMEG), 
B. psychrophilus (BPSY) B. subtilis (BSUB), C. acetobutylicum (CACE), C. clariflavum (CCLA), C. clostridioforme (CCLO), C. leptum  (CLEP),  
C. ljungdahlii (CLJU), C. papyrosolvens (CPAP), C. ramosum (CRAM), L. grayi (LGRA), L. monocytogenes (LMON), L. Seeligeri serovar (LSEE), 
L. lactis (LLAC), M. leprae (MLEP), M. tuberculosis (MTUB), Staph. aureus (SAUR), Staph. capitis (SCAP), Staph. hominis (SHOM),  
Staph. lugdunensis (SLUG), Staph. pettenkoferi (SPET), Strep. cristatus (SCRI), Strep. downei (SDOW), Strep. equinus (SEQU),  
Strep. mutans (SMUT), Strep. pneumoniae (SPNE), Strep. suis (SSUI), Strep. thermophilus (STHE), T. tengcongensis (TTEN), T. wiegelii (TWIE),  
T. xylanolyticum (TXYL).   
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3.2.5 Cloning, Expression and Purification of LCA 
3.2.5.1 Cloning of IPMDH LCA 
The consensus sequence of LCA was synthesised by GENEART (Regensburg, 
Germany) with codons optimised for expression in E. coli.  The gene was 
excised from the pMA-T vector, cleaned up and ligated into pPROEX as 
described in section 2.2.3.  Plasmids were transformed into electrocompetent 
E. coli DH5α cells as described in section 2.2.4.2.  The presence of the LCA 
gene in transformant colonies was checked from overnight cultures through 
plasmid extraction and restriction digest (section 2.2.4.4).  An agarose gel of the 
plasmid restriction digest products is shown in Figure 3.4.  For the colonies 
corresponding to lanes 3 and 4, a band for the excised LCA gene is present at the 
expected size (1150 bp) indicating successful ligation of the LCA gene.  A 
glycerol stock (section 2.2.4.5) was prepared from the overnight of a successful 
transformant.   
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Figure 3.4: Agarose gel of the plasmid restriction digest screen for correct 
ligation of the LCA gene into pPROEX. 
Lane 1, 1 kb plus DNA ladder; lanes 2 – 5, pPROEX plasmids purified from 
transformant colonies, digested with the restriction enzymes XhoI and PstI.  
Plasmid from colonies in lanes 3 and 4 show an excised fragment at the 
correct size (1150 bp) of the LCA gene.   
3.2.5.2 Expression and Purification of LCA 
Following successful cloning, the LCA enzyme was expressed and purified, as 
per the protocol in Hobbs et al. (2012) (see sections 2.3.1 and 2.3.2).  Expression 
at 37 °C resulted in low protein yields following nickel affinity chromatography.  
Therefore, protein expression was trialled at 18 °C to attempt to increase the 
protein yield.  Results from this expression are shown in Figure 3.5. 
 
A SDS-PAGE gel of the insoluble fraction (Figure 3.5) showed that a 
predominant portion of the protein was insoluble.  However, significant amounts 
of soluble LCA were also detected in the supernatant. 
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Figure 3.5: Expression trial of LCA at 18 °C.   
Lane 1, protein ladder; lane 2, insoluble pellet; lane 3, supernatant  
 
Soluble LCA protein from the supernatant was purified by nickel affinity 
chromatography.  The trace from this purification, given in Figure 3.6, shows 
low protein yield compared to similar purifications of ANC1, ANC4 and BCVX 
(see Figure 4.1 for representative ANC4 nickel affinity chromatography results).  
Protein elution occurred at around 30 % elution buffer.  A SDS-PAGE gel of 
fractions corresponding to the absorption peak confirmed that LCA protein was 
present in the fractions, and was reasonably pure, with only faint bands of 
contaminating proteins (Figure 3.6).   
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B 
 
A 
 
Figure 3.6: Nickel affinity chromatography of LCA expressed at 18 °C.  
(A)  Trace from nickel affinity purification, measured at 280 nm; (B) SDS-
PAGE gel of nickel trace fractions.  Lane 1, ladder; lanes 2 – 6, fractions 
from 33 to 40 ml of elution volume.   
 
Size exclusion chromatography of pooled nickel affinity chromatography 
fractions gave results inconsistent with the expected dimeric size (84 kDa) of the 
protein.  As shown in the trace in Figure 3.7 A, protein is eluted from the column 
just after the void volume, characteristic of a large molecular weight.  This was 
considerably different to the elution of other IPMDH enzymes (see Figure 4.2) 
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where protein is eluting at around 14 ml of elution volume.  LCA was expected 
to form a dimer of similar molecular weight to other IPMDH enzymes, and thus 
have a similar SE elution volume.  The small peak eluting from the column at 16 
ml, consistent with the dimeric size of the protein, was shown not to be LCA 
based on the protein size when further analysed by SDS-PAGE (Figure 3.7 B, 
lanes 6 - 10).  The elution characteristics, coupled with the SDS-PAGE gel 
(Figure 3.7 B, lanes 2 - 5) showing the correct size for the monomeric protein 
unit, and the clear appearance of the protein containing fractions indicated that 
the protein was forming a soluble aggregate.  LCA proteins also showed no 
activity in the standard IPM oxidation assay (section 2.3.3).      
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A 
 
B 
 
Figure 3.7: SE purification of LCA protein. 
(A) SE column trace of LCA purified from culture grown at 18 °C, 
measured at 280 nm; (B) SDS-PAGE gel of SE fractions.  Lane 1, ladder; 
lanes 2 – 5, SE fractions from 7 to 10 ml of elution volume; lanes 6 – 10, 
fractions from 15 ml to 16.5 ml of elution buffer.  
 
Soluble aggregates can be caused by a number of factors, and are generally 
difficult to rectify (Cromwell et al. 2006).  One cause of soluble aggregates that 
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was identified as a possible cause of LCA aggregation was disulfide bridges 
between molecules.  Analysis of the sequence of LCA compared to known 
active dimeric enzymes (ANC1, ANC4 and BCVX) showed that an additional 
cysteine is present at position 46 of the LCA sequence.  A cysteine is also 
present at position 63 in the LCA sequence.  The possibility this was causing the 
soluble aggregate was tested by the addition of 1 µM of the reducing agent β-
mercaptoethanol to the standard SE buffer and protein during purification.  This 
yielded no change to the point the protein eluted from the column.  Therefore it 
was concluded that disulfide bonds were not the cause of the soluble aggregate.  
The formation of a soluble aggregate for LCA was concluded to be most likely 
due to a misfolded protein due to errors in the ancestral inference. 
 
From this result it was concluded that the inference methods used were not 
sufficient given the time scale and sequence divergence of the IPMDH protein 
over the Firmicutes.  This has been further substantiated with subsequent work 
on the reconstruction of this ancestor (Groussin et al, unpublished).  Successful 
inference of IPMDH back to the LCA of the Firmicutes has been achieved by 
way of a larger phylogenetic tree of 70 sequences reconciled against a species 
tree based on 16S sequences with or without a more sophisticated model of 
evolution incorporating heterogeneity into the evolution rate of residue sites.  
Incorporation of site heterogeneity more accurately accounts for the structural 
and functional constraints on certain sites of the sequence, and the reconciled 
tree accounts for events such as duplication, horizontal gene transfer and gene 
loss.  Use of the reconciled tree with either the more sophisticated model or the 
LG model resulted in ancestral proteins with biological properties similar to 
contemporary IPMDHs.  The use of the more sophisticated model with an 
IPMDH sequence only tree also resulted in an active enzyme, however a high 
kcat and low kinetic barrier to unfolding despite high Topt indicate errors in the 
inference.  Thus, for reconstructions back over large time periods in complex 
enzymes with significant levels of sequence divergence, it seems that more 
rigorous inference methods are required, especially the reconciliation of the 
sequence tree against a species tree.    
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In summary, ASR techniques have been applied to the reconstruction of IPMDH 
from the LCA of the Firmicutes.  This reconstruction tested the limits of ASR 
techniques in terms of the time scale and level of divergence across 
contemporary sequences.  However, once reconstructed, the inferred LCA 
enzyme was found to be inactive, and to form a soluble aggregate.  For 
reconstructions of this level of sequence divergence, it seems that more 
sophisticated ASR methods are required to successfully infer the ancestral 
sequence.         
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4 Substrate Promiscuity and in vivo Fitness of 
IPMDH Ancestors  
4.1 Introduction  
Enzymes are believed to have started off as generalists, catalysing a wide range of 
reactions.  Over time these generalists have evolved into specialists acting 
proficiently in the catalysis of one substrate (Jensen 1976; Depristo 2007; 
Hernandez-Montes et al. 2008).  Given this, ancestral enzymes should show 
greater activity on a wider range of substrates than their contemporary 
counterparts.            
 
The previous reconstruction of ancestral IPMDH from Bacillus revealed an 
interesting trend regarding the evolution of enzymatic rate and kinetic stability 
over the history of the enzyme (Hobbs et al. 2012).  ANC1 (approximately 670 
mya – refer to chronogram in Figure 1.5) and ANC4 (approximately 950 mya) 
showed significantly faster catalytic rates than contemporary enzymes measured 
(kcat of 141.8 s
-1
 and 362.2 s
-1
 respectively, compared to 53.8 s
-1
 for IPMDH 
BCVX, the fastest measured contemporary IPMDH).  In addition to this, ANC4 is 
more kinetically stable, with a free energy of unfolding (ΔGǂN-U) of 110.8 kJ mol
-1
, 
compared to 100.7 kJ mol
-1 
and 100.9 kJ mol
-1 
for BCVX and ANC1 respectively.  
This trend begs the question, if these ancestral enzymes were so fast and stable, 
why have they been lost over evolutionary time in favour of catalytically slower 
and less stable equivalents?  This question was addressed by assessing the effect 
the ancestral IPMDH enzymes have in a cellular context while functioning within 
the normal biosynthetic pathway of leucine to see if the fast catalytic rate of 
ANC1, or fast catalytic rate and kinetic stability of ANC4 have any fitness costs 
in vivo.   
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4.2 Results and Discussion  
4.2.1 Expression and Purification of ANC1, ANC4 and BCVX 
ANC1, ANC4 and BCVX IPMDH proteins were expressed via IPTG induction in 
TB media at 37 °C as described in section 2.3.1 [as per methods from Hobbs, et 
al. (2012)].  Cells were pelleted from overnight culture, sonicated to achieve lysis, 
and centrifuged to separate cell debris.  The protein was separated from the 
supernatant and majority of other proteins by nickel affinity chromatography via 
N-terminal hexa-histidine tag.  Protein was removed from the nickel affinity 
column via gradient elution against increasing concentrations of imidazole 
(section 2.3.2.2).  The SE trace and SDS-PAGE gel of this process is shown in 
Figure 4.1.  SDS-PAGE lanes corresponding to the insoluble pellet and 
supernatant show that most of the ANC4 protein is soluble, with only a small 
proportion in the insoluble pellet.  In the nickel affinity column flow through, 
ANC4 IPMDH protein has been removed from solution and separated from the 
other proteins evident in the solution.  Protein elution from the SE column can be 
seen in the UV trace at 280 nm around 30 % buffer B (about 300 mM imidazole).  
The SDS-PAGE gel shows the SE fractions collected are comprised 
predominantly of the target ANC4 protein, with a few minor protein impurities 
present.     
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A 
 
B 
 
Figure 4.1: Nickel affinity purification of ANC4 protein.   
(A) Elution trace of ANC4 during nickel affinity chromatography against an 
increasing concentration of imidazole.  Protein elution was followed at 280 
nm; (B) SDS-PAGE gel from nickel affinity purification of ANC4.  Lane 1, 
protein ladder; lane 2, insoluble pellet; lane 3, supernatant; lane 4, nickel 
affinity column flow through; lanes 5 – 9, fractions from 34 to 44 ml of 
elution volume from the nickel column elution trace.   
 
Pooled protein containing fractions from the nickel affinity column were further 
purified by SE chromatography as described in section 2.3.2.3.  A trace of the SE 
process for ANC4 and the corresponding SDS-PAGE gel are given in Figure 4.2.  
Elution of the protein occurs at around 15 ml, consistent with a protein dimer.  
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The SDS-PAGE gel of protein containing fractions shows that the protein is 
largely pure at this stage, with only minor impurities present in the fractions.  
 
A 
 
B 
 
Figure 4.2: SE column purification of ANC4 protein. 
(A) SE trace at 280 nm of ANC4 elution; (B) SDS-PAGE gel of selected 
fractions from SE purification of ANC4.  Lane 1, protein ladder; lanes 2 – 8, 
fractions from 12.5 to 15.5 ml of elution volume from the SE elution trace. 
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ANC1 and BCVX proteins were successfully purified by the same methods 
described here.  Nickel affinity chromatography and SE column traces, and SDS-
PAGE gels were similar to the representative examples given for ANC4.   
4.2.2 Characterisation of Activity with Alternative Substrates 
Contemporary IPMDHs catalyse oxidative decarboxylation of a range of 
alkylmalates (Miyazaki et al. 1993; Matsunami et al. 1998).  The general structure 
of alkylmalates, as well as the native and alternative substrates of IPMDH are 
given in Table 4.1.  Alternative substrates for IPMDH were assessed to test the 
hypothesis than substrate promiscuity will increase with older ancestral enzymes.   
 
Table 4.1: Chemical structures of the native substrate of IPMDH, and the 
alternative substrates assayed in this study.   
 
IPM 
 
 
Alkylmalate 
 
Where R is an alkyl chain 
 
Malate 
 
 
Tartrate 
 
 
Isocitrate 
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4.2.2.1 Substrate specificity of Alternative Substrates 
Kinetic analysis of ANC1, ANC4 and BCVX enzymes with alternative substrates 
was performed as described in section 2.3.3.1.  BCVX was chosen as the extant 
species for comparison due to its similar Topt to the two ancestral enzymes being 
investigated.  Kinetic analyses of alternative substrates for the IMPDH enzyme 
were performed at the previously determined Topt of each enzyme (Hobbs et al. 
2012). 
 
Initially, KM determinations for each enzyme with the alternative substrates was 
attempted.  These were performed with an excess of the cofactor NAD
+
, and 
increasing concentrations of the substrate till a plateau in rate occurred.  These 
data is shown in Figure 4.3.  Data was plotted in GraphPad Prism Version 5 
(GraphPad Software, USA) using the Michaelis Menten function, however this 
function gave a poor fit to the data in most cases.  
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.  
  
  
  
Figure 4.3: Activity assays performed for the alternative substrates for the 
enzymes ANC1, ANC4 and BCVX at the Topt of each respective enzyme.  
Data was concluded not to be suitable for Michaelis Menten kinetic analysis.  
 
Plots which fit Michaelis Menten curves well were produced by BCXV with both 
substrates and ANC4 with tartrate.  However issues are apparent in the remainder 
of the plots which resulted in ill fitting Michaelis Menten curves.  In these cases, 
issues are apparent with either a failure of the data to plateau off (often due to 
substrate solubility issues, especially with tartrate) or the data not passing through 
zero.  ANC1 with tartrate, and to a lesser extent ANC4 with tartrate, show a slight 
lag in activity at low substrate concentrations.  Substrate inhibition at high 
concentrations of malate is also evident for BCVX.  These effects resulted in 
inaccurate KM and Vmax values, which were not suitable for comparison to evaluate 
the efficiency of each enzyme with the alternative substrates. 
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Due to the issues encountered with the Michaelis Menten kinetic analysis, a 
measurement of specific activity was used instead.  
4.2.2.2 Specific Activity Determination for the Alternative Substrates  
Specific activities were measured by the process in section 2.3.3.1 at the Topt of 
each enzyme.  Substrate was kept at a constant concentration between each 
enzyme.  Substrate concentration was chosen based on the activity seen in the 
assay curves in Figure 4.3 so that a reasonable level of activity would be 
measured for each enzyme.  Use of specific activity to compare enzymes also 
allowed isocitrate to be included in the analysis, as low solubility rendered 
Michaelis Menten analysis of this substrate unfeasible. 
 
Table 4.2: Specific activities of ANC1, ANC4 and BCVX on the alternative 
substrates at the Topt of the respective enzymes.   
  ANC1 ANC4 BCVX 
  
(mM product s
-1
 mM 
protein
-1
) 
(mM product s
-1
 mM 
protein
-1
) 
(mM product s
-1
 mM 
protein
-1
) 
Malate       
(0.2 M) 1.6 ± 0.2 10.3 ± 0.1  3.2 ± 0.2 
        
Tartrate       
(0.15 M) 0.7 ± 0.1 14 ± 1 2.9 ± 0.3 
        
Isocitrate       
(0.2 M) 0.90 ± 0.06  0.084 ± 0.004 1.03 ± 0.05 
        
Errors are reported as the SD of the replicates.  Substrate concentrations 
used are given under the respective substrates.  
      
ANC1 and BCVX showed similar low levels of catalysis against all three 
alternative substrates tested.  ANC4 was expected to be faster with alternative 
substrates than ANC1 and BCVX as it is already known to be significantly faster 
on the natural substrate, IPM (kcat of 362.2 s
-1
 compared to 141.8 s
-1
 and 53.8 s
-1
 
and ANC1 and BCVX respectively).  This was observed for malate and tartrate, 
however not with isocitrate, where a ten-fold decrease in activity compared to 
ANC1 and BCVX was found.  Based on the age of the citrate cycle from which 
isocitrate is derived (Cunchillos & Lecointre 2003), isocitrate would have been an 
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encountered substrate 950 mya, at the time ANC4 was active.  This does not 
support the idea that substrate specificity increases with age, as the most distant 
enzyme in the tree shows significant levels of activity with fewer substrates than 
the more recent descendents.  This is similar to the conclusion drawn by Wouters, 
et al. (2003) where it was found that enzyme specificity over time is not a linear 
process.  These results are not in agreement with the trend from generalist to 
specialist that has been found in ancestral β-lactamases (Risso et al. 2013).  
Without knowing the exact environment and compounds the ancestral enzymes 
were in contact with and the availability and necessity of these compounds, it is 
difficult to rationalise the activity of ancestral enzymes on various substrates.  It is 
also possible that the reconstruction has not been taken back to old enough 
ancestors to measure increases in substrate promiscuity.       
4.2.3 In vivo Characterisation  
To investigate the possible reasons why ANC1 and ANC4 have been lost over 
evolutionary time and superseded by catalytically slower and kinetically less 
stable equivalents, the fitness of these enzymes in vivo was investigated.  Growth 
rates were used to determine if the fast catalysis of ANC1 and ANC4 and the 
stability of ANC4 correlated to in vivo fitness, or if these enzymes have growth 
rate costs that are not reflected by the in vitro parameters.  
4.2.3.1 Strain Construction  
To investigate the effect the enzymes ANC1, ANC4 and BCVX have on the 
growth rates of cells, the pPROEX expression constructs were transformed into 
Keio collection E. coli cells which have had the natural IPMDH gene knocked out 
(referred to as the leuB KO).  Although the use of E. coli and an over expression 
vector have limitations, this system offered a preliminary set up to investigate the 
effect of the ancestral and extant enzymes on growth rate.  The constructs were 
also transformed into E. coli strains with the tartrate dehydrogenase (yeaU), 
malate dehydrogenase (mdh) and isocitrate dehydrogenase (icd) genes knocked 
out to investigate how well each IPMDH enzyme complemented the normal 
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oxidation enzyme for the alternative substrates.  A table of the cell lines created is 
available in Appendix A2.      
4.2.3.2 Plate Growth Trials 
To determine which carbon source to grow each KO on to distinguish between 
successfully and unsuccessfully complemented strains, cells were streaked from 
glycerol stocks onto M9 agar (Appendix C2) supplemented with various carbon 
sources, 100 µg/ml AMP and 1 mM IPTG as described in section 2.4.2.1.  An 
appropriate carbon source was determined by growth of the parent strain with no 
gene knocked out, and no growth of the KO complemented with empty pPROEX 
vector.  Results of this are illustrated in Figure 4.4. 
 
  
A) leuB KO, glucose carbon source B) icd KO, glucose carbon source 
  
C) yeaU KO, malate carbon source D) mdh KO, malate carbon source  
Figure 4.4: KO controls grown on M9 agar supplemented with various 
carbon sources as indicated, 100 µg/ml AMP and 1 mM IPTG.   
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Glucose (10 g/L) was found to be an appropriate carbon source for the leuB 
(Figure 4.4 A) and icd (Figure 4.4 B) KO strains by the growth of the parent 
strain, and lack of growth of the KO strain complemented with pPROEX only, 
consistent with previously reported results (Kabir & Shimizu 2004; Chen et al. 
2011).  D-malate (2 g/L) was successful for growing the yeaU KO strain [Figure 
4.4 C; (Reed et al. 2006)].  Despite trialling a number carbon sources (malate, 
succinate and acetate) reported as appropriate for growth of the mdh KO (van der 
Rest et al. 2000), no source was found which eliminated growth of the KO strain 
complemented with pPROEX (Figure 4.4 D).   
 
It is possible that the negative control for the mdh KO in which the malate 
dehydrogenase enzyme is removed and not complemented with any replacement 
gene is showing growth due to gene compensation.  It is well documented that 
many enzymes can catalyse multiple reactions with different substrates.  In vivo 
this can result in another enzyme performing the role of missing gene, thus 
compensating for the function and mitigating the KO phenotype (Khersonsky & 
Tawfik 2010).  As no carbon source was found which gave growth dependent on 
the plasmid introduction of a gene to complement the KO, no further analysis of 
the mdh KO was able to be performed.  
 
Relative growth rates of each complemented KO were determined on M9 medium 
by plating out a series of diluted overnight culture as described in section 2.4.3.1.  
Overnights were grown in LB to achieve equal growth over all complemented 
KOs.  Prior to plating, cells were washed twice in M9 medium to remove any 
residual LB and components of this medium which may facilitate growth in a 
manner not reliant on the activity of the complemented gene.   Growth results are 
shown in Figure 4.5.  For the leuB KO, all three introduced genes rescued the KO.  
Growth rates for ANC1 and BCVX are comparable, showing growth right through 
to the lowest dilution.  ANC4, however, showed significantly poorer growth 
compared to the other two strains.  Complemented icd and yeaU KOs all showed 
only slight levels of growth.  Less growth of these yeaU and icd KOs compared to 
the leuB KO was expected given the low levels of catalysis measured for IPMDH 
against the alternative substrates in vitro.  Both ancestral IPMDHs showed slightly 
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better rescue of growth than the contemporary BCVX in the icd KO.  In the yeaU 
KO, the ancestral and contemporary IPMDH genes showed approximately equal 
levels of growth.   
 
Substrate Promiscuity and in vivo Fitness of IPMDH Ancestors                                        
74 
 
A 
 
B 
 
C 
 
Figure 4.5: Relative growth rates on M9 agar of the Keio collection KOs 
complemented with extant and ancestral IPMDH genes.   
(A) leuB KO with glucose carbon supply; (B) icd KO with glucose carbon 
supply; (C) yeaU KO with malate carbon supply.   
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4.2.3.3 Growth Rate Determination  
 As plate growth is only a semi-quantitative measure, growth rates in liquid M9 
medium were determined.  Starter cultures in M9 medium were inoculated at a 1 
in 100 dilution from LB overnights and grown for 48 hours at 37 °C to achieve 
sufficient cell density.  These were then used to inoculate cultures for growth rate 
determination.  Growth rate determination was performed with 100 μl cultures in 
a shaking plate incubator with OD measurements at 600 nm performed every 20 
minutes until stationary phase was entered as described in section 2.4.3.1.  This 
method was found to give consistent growth curves for the leuB KOs, as shown in 
Figure 4.6.     
4.2.3.3.1 Growth Rates of icd and yeaU Knock Outs 
Complemented strains of the icd and yeaU KOs showed insignificant levels of 
growth over up to 70 hour growth periods.  This indicates that IPMDH is too 
inefficient at catalysing the oxidation of isocitrate and tartrate, respectively, to 
complement the knocked out gene effectively and allow growth.  This is 
especially significant considering that in this system IPMDH is being expressed at 
intracellular concentrations higher than normal levels. If expressed at natural 
intracellular concentrations, all three variants of IPMDH tested would be even less 
able to complement the icd and yeaU KOs.   
4.2.3.3.2 Growth Rates of leuB Knock Outs 
This method was found to produce consistent growth curves for the leuB KOs.  
Representative growth curves are given in Figure 4.6.  Of interest is the large over 
growth of ANC4 before dropping back to the final cell density.  All three variants 
displayed approximately the same OD at final density, however ANC1 and BCVX 
showed no or minor growth above this level before stabilising.  Although the 
significance of this is unknown, the overshoot suggests unregulated cell growth, 
and may be related to the greater ability of ANC4 to turnover IPM.  However, it 
appears the cells over use resources in the media, resulting in a drastic drop in OD 
back to similar levels as ANC1 and BCVX complemented strains.  The greater lag 
observed for BCVX compared to ANC1 and ANC4 despite the similar levels of 
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exponential phase growth is also of interest.  The significance of this is also 
unknown, and would require further investigation.    
 
 
Figure 4.6: Representative growth curves for Keio collection leuB KOs 
complemented with extant and ancestral IPMDH genes. 
 
From the growth curves, data from the log phase of growth was used to determine 
the specific growth rate (μ) by taking the slope of a ln OD versus time graph 
(Breidt et al. 1994).  Specific growth rates were then converted to the doubling 
time of the culture using the following equation: 
 
Specific growth rate = ln2/μ 
 
Doubling times are reported in Table 4.3.  A complete set of growth curves for 
complemented leuB KOs is available in Appendix D.  Raw data is available on the 
attached disk.    
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Table 4.3: Doubling times of leuB KOs complemented with ancestral and 
contemporary IPMDH genes in M9 medium with 10 g/L glucose as a carbon 
source.  
Complemented strain Doubling time (h) 
  Average 
ANC1 2.6 ± 0.7 
ANC4 2.6 ± 0.6 
BCVX 3.1 ± 0.4 
Doubling times are the mean of 3 biological replicates, each with 3 
internal replicates.  Errors are reported as the pooled SD of the 
replicates.  
 
The determined doubling times showed high levels of variability.  Internal 
replicates of growth rate from the same inoculum generally gave consistent 
doubling times, however larger variability was present between biological 
replicates.  Overall the results do not show statistically significant differences in 
doubling times between the different ancestral and extant enzymes, and contradict 
the observed plate growth trends.  
 
Subsequently, significant differences between in vivo growth rates for these 
IPMDH variants has been successfully shown (Hobbs et al, unpublished).  
Ancestral and extant IPMDH expression was under the control of the natural leu 
operon promoter, cloned into the pUC19 plasmid.   Growth rates correlated with 
the trends seen in the plate growth trials in section 4.2.3.2, where ANC1 and 
BCVX showed greater levels of growth than the KO complemented with the 
ANC4 gene.  The inability to observe this trend in growth rate with the pPROEX 
system is likely due to the artificially high levels of enzyme resulting from the 
overexpression vector.  Despite the equal addition of IPTG to induce enzyme 
expression, this system is not guaranteed to give equal expression over all variants 
or replicates.  The abnormal cellular compositions created by IPMDH 
overexpression also has the potential to disrupt normal cellular functions and 
obscure growth rate differences present between the variants.   
 
The decreased fitness of ANC4 in vivo seen in plate growth and by Hobbs et al 
(unpublished) explains the loss of this enzyme over evolutionary time despite the 
faster rate and greater kinetic stability measured in vitro.  This lowered in vivo 
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fitness could be due to a variety of factors.  The fast turnover of substrate by 
ANC4 potentially consumes too much of the cofactor NAD
+
, disrupting other 
reactions dependent on NAD
+
.  Excessive build up of reaction product could also 
have adverse effects on cells.  The kinetic stability of ANC4 may also cause 
issues in the regulation of the pathway if slower turnover rates of the enzyme 
affect the fine scale control needed in the biosynthetic pathway.  Further 
investigation is necessary to determine the reasons for slower growth of ANC4 
than ANC1 or the contemporary BCVX.    
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5 The X-ray Crystal Structure of ANC1 
X-ray crystallography is a technique used to determine the 3D structure of 
proteins.  This technique relies on the crystallisation of a protein into a well 
ordered lattice.  X-ray beam photons can then be diffracted by the electrons of 
atoms within the protein crystal, resulting in a diffraction pattern.  This diffraction 
pattern contains information in the amplitude and position of each spot.  However, 
phase information, which is also required for transforming the data into a 3D 
protein structure, cannot be determined directly from the diffraction pattern.  
Phase information can be recovered directly from the crystal by various 
anomalous diffraction methods, or through molecular replacement techniques.  
Molecular replacement relies on a similar protein structure from which phase 
information can be inferred.  With phase information, the diffraction pattern can 
be transformed into an electron density map, into which the protein sequence can 
be built.   
 
A number of structures for IPMDH have previously been solved, including that of 
ANC4.  The structure of ANC1 would give a more complete structural view of 
IPMDH evolution in Bacillus, and the differences present between ANC1 and 
ANC4.   
 
5.1 Results and Discussion 
5.1.1 Crystallisation of IPMDH ANC1 
Crystallisation screens of 384 conditions (Hampton Research, USA) were set up 
for ANC1 with and without additives (NAD
+
 and Mn
2+
).  Crystallisation screens 
were performed by the sitting drop method as described in section 2.5.3.1.  For the 
crystallisation screen with additives, small crystals were observed in a number of 
conditions.  Three conditions were carried through to fine screens, where the pH 
and concentration of precipitant were varied.  Crystals resulting from these fine 
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screens were too small for data collection, therefore crystal seeding (section 
2.5.3.2) was performed from a fine screen around a condition with 0.1 M sodium 
citrate tribasic, pH 5.6, 20 % v/v propan-2-ol and 20 % w/v PEG 4,000.  Batch 
seeding and streak seeding were attempted from various conditions from the 
initial fine screen.  Batch seeding from a 1 in 10,000 dilution of the original fine 
screen crystal drop resulted in larger crystals (Figure 5.1).  Crystals were tested 
for diffraction on a SuperNova X-ray diffractometer (Agilent, USA; section 
2.5.5), however no diffraction resulted from these crystals.  
 
A B 
  
Figure 5.1: IPMDH ANC1 crystals with additives.    
Crystals were grown in 0.1 M sodium citrate tribasic, pH 5.2, 20 % v/v 
propan-2-ol and 20 % w/v PEG 4,000, with additives of NAD
+
 (1 mM) and 
MnCl2 (0.2 mM).  (A) initial crystals formed in a hanging drop fine screen; 
(B) crystals formed from batch seeding (1 in 10,000) from crystals in (A).   
 
In the crystallisation screen without additives, crystals formed in a solution 
containing 0.2 M NaCl, 0.1 M sodium acetate, pH 4.6 and 30 % v/v 2-methyl-2,4-
pentanediol (MPD).  The pH and concentration of the precipitant (MPD) were 
altered in the fine screening process.  Good crystals were formed across many of 
the fine screen conditions, an example of which is given in Figure 5.2.  Testing of 
these crystals on a SuperNova X-ray diffractometer (Agilent, USA; section 2.5.5) 
showed good diffraction out to 2.5 Å resolution.  
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Figure 5.2: IPMDH ANC1 crystals.   
Crystals were grown in 0.2 M NaCl, 0.1 M sodium acetate trihydrate, pH 4.8 
and 30 % v/v MPD.  The final crystal structure was solved from the cubic 
crystal situated to the bottom right of the image.  
5.1.2 X-ray Data Collection 
Crystals giving good diffraction were sent to the Australian Synchrotron for data 
collection.  Data were collected for the cubic crystal shown in Figure 5.2 to 2.3 Å 
resolution. Diffraction data are shown in Figure 5.3.  Data were also collected 
with increased attenuation giving a low resolution data set due to the presence of 
overloaded spots in the high resolution data set.  Diffraction data were collected 
over 360° in 1° increments for both data sets, with detector distances of 180 mm 
and 220 mm for the high resolution and low resolution data sets, respectively.  No 
deterioration of the crystal diffraction was observed over the collection of the two 
data sets.   
 
The X-ray Crystal Structure of ANC1 
82 
 
 
Figure 5.3: X-ray diffraction pattern of IPMDH ANC1.   
The image boundary represents 1.85 Å resolution.    
5.1.3 Data Processing  
The space group for the data was determined in MOSFLM (Leslie & Powell 
2007) to be P42212, with a tetragonal unit cell.  The high and low resolution data 
sets were integrated in MOSFLM separately.  The two integrated data sets were 
combined in Sortmtz (P. J. Daly, Daresbury) within the CCP4 program suite 
(Winn et al. 2011).  The integrated and combined reflections were scaled and 
merged in SCALA (Evans 2006) with a resolution cut off at 2.6 Å.  Matthews 
coefficient analysis (Matthews 1968) predicted two molecules in the asymmetric 
unit.  Data collection statistics are provided in  
Table 5.1. 
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Table 5.1: Data collection statistics for IPMDH ANC1. 
Data statistics Overall Outer shell 
Space group P42212  
Wavelength (Å) 0.9686  
Cell dimensions   
       a b c (Å) 111.92/119.92/62.26  
       α β γ 90/90/90  
Mosaicity 0.957 (1.013)  
Monomers in the asymmetric unit 2  
Resolution range (Å) 41.65-2.6 2.74-2.6 
Number of observed reflections 624430 86097 
Number of unique reflections 12703 1808 
Rmerge 0.112 0.697 
Mean I/σI 28.9 7.3 
Completeness 100 100 
Multiplicity  49.2 47.6 
Values in parenthesis are for the low resolution dataset.  Statistics with only 
one value given are the same value for the two sets or for the combined data. 
5.1.3.1 Molecular Replacement, Model Building and Refinement of ANC1 
 Molecular replacement was performed in Phenix (Adams et al. 2010) using the 
previously solved ANC4 structure (PDB code 3U1H).  The two proteins are 
closely related, with 82.4 % sequence similarity.  The model was further 
improved using AutoBuild within the Phenix software.  The model was built 
manually in COOT (Emsley & Cowtan 2004) into 2ǀFOǀ-ǀFCǀ and ǀFOǀ-ǀFCǀ maps 
contoured to 1 σ and 3 σ, respectively.  Refinement of the model was performed 
in Phenix. 
 
The final model has an R-factor of 23.21 % and an Rfree of 29.01 % (see Table 5.2 
for a full list of refinement statistics). There were a number of residues in the 
structure that were not able to be resolved.  Areas which were unable to be 
resolved were the N and C termini, as well as three loop regions situated at the 
periphery of the structure.  A total of 320 of the 369 amino acids were able to be 
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modelled successfully.  A number of side chains also lacked density throughout 
the structure.  Electron density was also found to accommodate acetate and 
glycerol molecules.  The average B factor for the protein is 49.3 Å
2
.  
Ramachandran analysis by Procheck in the CCP4 program suite (Winn et al. 
2011) revealed that 91.0 % of residues are in favoured regions, 8.7 % are in 
allowed regions and 0.3 % are in disallowed regions.   
 
Table 5.2: Refinement and model statistics for ANC1. 
Refinement and model statistic  
R-factor 23.21 
Rfree 29.01 
Total number of atoms 2518 
Total number of protein atoms 2441 
Other ions/molecules 2 
Number of waters 56 
RMSD  
     Bond lengths (Å) 0.008 
     Bond angles (°) 1.157 
Average B factors (Å
2
)  
     Protein monomer 49.3 
     Waters 48.0 
Ramachandran analysis   
     Percentage in favoured regions 91.0 
     Percentage in allowed regions 8.7  
     Percentage in disallowed regions 0.3 
 
5.1.4 Structure of IPMDH ANC1 
The X-ray crystal structure of ANC1 was solved at a resolution of 2.6 Å.  The 
structure of ANC1 is shown in Figure 5.4.  ANC1 is similar to previously solved 
IPMDH structures, comprising of two domains of helices with a twisted central 
plane of ten β strands.  This conformation results in two clefts in the structure.  
The active site is situated in one of these cavities, at the front of the image in 
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Figure 5.4 A.  Missing regions can be seen on the periphery of the structure in the 
loops connecting α helix and β sheet structures.    
 
B-factors of the structure are higher in domain 1, as illustrated in Figure 5.5.  
Peripheral loops show the highest B-factors.  By comparison domain 2, where the 
dimer interaction occurs, is more static.  B-factors throughout the centre of the 
protein are considerably lower than the rest of the structure. 
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A B 
  
C 
 
Figure 5.4: Cartoon representation of the monomeric unit of ANC1 IPMDH.   
(A) side view of ANC1; (B) top view of ANC1.  Spectrum colouring starts at 
the N terminus in dark blue, and ends at the C terminus in red; (C) 
schematic topology of ANC1 IPMDH structure.  α helix and β sheet 
numbering is indicated.  Components are coloured to correspond to the 
colouration used in (A) and (B).  Gaps in the structure are indicated with red 
lines.  
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Figure 5.5: Cartoon representation of ANC1 coloured according to B-factors.  
B-factors are indicated based on spectrum colouration, where red represents 
high B-factors, and dark blue represents low B-factors.  The second 
monomer in the dimeric unit has also been included in purple to illustrate the 
dimer interface.  
 
Active site residues in ANC1 were determined based on a sequence alignment 
with IPMDH from T. thermophilus and A. ferrooxidans, for which structures have 
been determined bound with NAD
+
 [(Hurley & Dean 1994); PDB code 1HEX] 
and IMP [(Imada et al. 1998); PDB code 1A05] respectively.  Active site residues 
are highlighted and numbered in Figure 5.6.  The active site is present in the cleft 
between the two domains of the structure, between α11 and α4 and backed by β4 
and β9.  NAD+ and IPM interacting residues, coloured red and blue respectively, 
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show the two areas in close proximity where the cofactor and substrate bind.  
Glu88, which is central to the recognition of the isopropyl moiety of the substrate 
as well as interacting with NAD
+
 (Imada et al. 1998), is indicated in purple.  
Glu80 and Arg148, interacting with NAD
+
 and IPM respectively, are positioned in 
loops for which electron density was not present in ANC1, and are thus not 
present in the structure.  Lys190 and Asp222 in domain 2 contribute to substrate 
binding between subunits, interacting with the malate backbone of IPM in the 
active site of the second subunit of the dimer.   
 
 
Figure 5.6: Carton representation of ANC1 showing the position of active site 
residues.     
Active site residues were identified based on the T. thermophilus structure 
crystallised with NAD
+
 [(Hurley & Dean 1994); PDB code 1HEX] and the 
A. ferrooxidans structure containing IPM [(Imada et al. 1998); PBD code 
1A05].  Residues are coloured to indicate the interactions they partake in: 
red, NAD
+
 binding residues; blue, IPM binding residues; orange, residues 
interacting with IPM between subunits of the dimer.  Glu88 (purple) 
interacts with both NAD
+
 and IPM.  Residue numbers are as indicated.  
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Compared to the A. ferrooxidans structure with IPM bound [(Imada et al. 1998); 
PDB code 1A05], there is a difference in the angle of the two domains about the 
active site.  When aligned by domain 1 (RMSD = 0.57 Å), domain 2 of ANC1 is 
more open by 4.9°, as measured from α11.  This open conformation is consistent 
with the crystallisation state of ANC1 without any substrate, cofactor or metal 
bound in the active site (Graczer et al. 2011a).    
 
The ANC1 dimer can be described based on the crystallographic symmetry of the 
two units comprising the dimer (Figure 5.7).  The two units interact through α9 
and α11, as well as a section of the loop connecting α5 and α6 in domain two.  
The two domains are in contact over an area of 971 Å
2
 as calculated by 
PDBePISA (Krissinel & Henrick 2007).    
 
 
Figure 5.7: Cartoon representation of the dimeric structure of ANC1.   
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5.1.4.1 Comparison to Other Structures 
Structural alignments of the ANC1 monomer with structures in the PDB revealed 
that ANC4 is the closest structural homologue of ANC1 (PDB code 3U1H).  
Structural alignment of the two enzymes had a Z-score of 20.5, an RMSD of 0.85 
Å, and high P- and Q- scores (46.6 and 0.81 respectively) over 317 aligned 
residues (Nalign).  The Z-score is a measure of the statistical significance of the 
structural alignment, with values greater than 3 considered to be significant.  The 
P-score is a measure of the negative logarithm of the probability of obtaining an 
identical or better structural alignment by chance, thus a higher P-score indicates a 
more significant structural match.  Q-scores give the quality of the alignment, 
where 1 indicates an identical structure.  Structural similarity was observed over a 
range of IPMDH structures in the PDB database.  The most similar bacterial 
structures are summarised in Table 5.3.  Given the relatively low sequence 
identity to T. thermophilus and A. ferrooxidans (56.6 % and 55.7 % respectively) 
there is a high level of structural correlation between ANC1 and these structures.   
ANC1 is more closely related to the IPMDH from the deep branching 
A. ferrooxidans than the contemporary B. coagulans.  This similarity to deep 
branching IPMDH structures supports the ancestral nature of the ANC1 enzyme.  
With the exception of C. jejuni, the most similar structures are from thermophilic 
species, suggesting a commonality between the IPMDHs adapted to function at 
higher temperatures.     
 
ANC1 and ANC4 are both structurally similar to T. thermophilus, 
A. ferrooxidans, and B. coagulans.  RMSD values for the structural alignment of 
ANC4 with these structures are 1.04 Å, 1.22 Å and 1.44 Å respectively.  ANC1 is 
more closely related to these contemporary enzymes than ANC4, as expected 
given the ages of the two ancestral enzymes.      
   
The X-ray Crystal Structure of ANC1 
91 
 
Table 5.3: PDBeFold structural alignment of PDB structures closely related 
to ANC1. 
Structure 
PBD 
code 
Q-
score 
P-
score 
Z-
score 
RMSD Nalign Reference 
ANC4 3U1H 0.81 46.6 20.5 0.85 317 
(Hobbs et 
al. 2012) 
T. thermophilus  2Y41 0.79 39.9 19.1 1.10 314 
(Graczer et 
al. 2011a) 
C. jejuni 3UDO 0.77 39.8 18.9 1.09 315 - 
A. ferrooxidans  1A05 0.75 36.6 18.8 1.18 315 
(Imada et 
al. 1998) 
B. coagulans 1V53 0.73 38.0 18.6 1.25 313 - 
 
Secondary structure matching (SSM) overlays for the two most similar structures 
to ANC1, ANC4 (PDB code 3U1H) and T. thermophilus (PDB code 2Y41), are 
illustrated in Figure 5.8 and Figure 5.9 respectively.  Both structures have very 
few structural differences compared to ANC1.  The major difference evident in 
both is the missing β loop from ANC1 that would be situated between β5 and α7 
if the region had been able to be modelled.  A smaller section of this loop is also 
missing in ANC4.  In the T. thermophilus dimer, these loops align in an 
antiparallel manner between the two monomeric units of this dimer, creating 
another intermolecular contact.  In the overlay of ANC1 and ANC4, domain 2 is 
very structurally similar.  Differences between the structures include β1 and β2 
which are angled in ANC1 so as to come into closer proximity to α1 than in 
ANC4.  A 1-2 Å displacement in α16 is also evident between the two structures.  
The angle that β9 and β10 orientate in the central plane of β sheets differs, 
positioning the loop that links these two components differently between the two 
structures.  Overall ANC1 an ANC4 are structurally very similar.  No differences 
between the two structures were identified to rationalise the biochemical 
differences between the two enzymes.  Nor was any commonality found between 
the two structures to explain the shared thermophilic nature of the two enzymes.  
This lack of thermophilic ‘signature’ between ANC1 and ANC4 has already been 
recognised from the amino acid compositions of the two enzymes (Hobbs et al. 
2012).  This suggests that thermophily has arisen twice, independently, over the 
evolution of IPMDH in Bacillus.  
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Figure 5.8: SSM overlay of ANC1 and ANC4 IPMDH structures. 
The ANC1 monomer is coloured with blue, while the ANC4 monomer (PDB 
code 3U1H) is coloured green.   
 
Domain 2 of ANC1 and T. thermophilus are also very structurally similar.  In 
domain 1, α1 and α16 are each displaced by between 2-3 Å.  The major difference 
between the two structures is in β9 and β10, which are considerably shorter in the 
T. thermophilus structure compared to ANC1 (β9 - 6.3 Å and 13.2 Å; β10 - 3.8 Å 
and 10.3 Å respectively).   The differences between ANC1 and both structures, 
with the exception of the shortening of β9 and β10, are on the periphery of the 
structure.  These regions are not likely to have significant effects on enzymatic 
catalysis, and differences may be the result of crystal packing.          
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Figure 5.9: SSM overlay of ANC1 and T. thermophilus IPMDH structures.  
The ANC1 monomer is coloured with blue, while the T. thermophilus 
monomer (PDB code 2T41) is coloured purple.   
 
In conclusion, the structure of ANC1 has been solved to 2.6 Å resolution.  ANC1 
was found to be structurally similar to previously solved contemporary IPMDHs, 
and ANC4, the LCA of Bacillus.  ANC1 was more structurally similar to 
contemporary structures than ANC4, consistent with the relative ages of the two 
enzymes.  No structural rational was found in a comparison of the two ancestral 
IPMDHs for the differences in biochemistry, or similarity in thermal activity of 
the two enzymes.   
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Discussion  
ASR techniques involving a site homogeneous model of evolution and protein 
sequence only phylogenetic tree have been applied to the inference of IPMDH 
from the LCA of the Firmicutes.  IPMDH has previously been successfully 
reconstructed back 950 myr to the LCA of Bacillus (Hobbs et al. 2012).  Taking 
this reconstruction of IPMDH back further to 2.7 billion years ago to the LCA of 
the Firmicutes tested the limits of ASR techniques in terms of time and sequence 
divergence.  In the ASR process, difficulties were encountered in the selection of 
species for inclusion in the ancestral inference, and in the consistency of 
phylogenetic trees produced.  These issues were overcome by selecting species 
representative of major groups within each of the main genera of the Firmicutes 
and selecting a phylogenetic tree with consistent grouping of species into the 
correct genera.  For the ancestral sequence inferences of the LCA of the 
Firmicutes, likelihood scores were slightly lower than optimal for the process 
(0.842 for the amino acid reconstruction, 0.815 for the nucleotide reconstruction 
and 0.693 for the codon reconstruction).  However, given the time scale and 
sequence variation of the reconstruction, these likelihood scores were deemed 
adequate.  The final LCA sequence shared between 47 % and 80 % sequence 
identity to contemporary and previously reconstructed IPMDH enzymes.  This 
indicates that no one contemporary enzyme is disproportionately influencing the 
LCA sequence, and that there is a reasonable level of sequence conservation over 
the IPMDH enzymes in the study.  The LCA gene was synthesised for 
biochemical characterisation.  During purification of the LCA enzyme, the protein 
was found to be forming soluble aggregates with no measurable catalytic activity.  
From this, it was concluded that the ASR techniques employed were not sufficient 
to reconstruct over the large time scale given the sequence divergence and 
structural complexity of IPMDH.   
 
Subsequently, the reconstruction of IPMDH from the LCA of the Firmicutes has 
been achieved (Groussin et al, unpublished).  This was achieved by the use of a 
larger phylogenetic tree reconciled against a species tree based on 16S sequences, 
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with or without a more sophisticated model of evolution incorporating site 
heterogeneity into the model of evolution.  It seems that to reconstruct over large 
time scales and levels of sequence divergence, more complex reconstruction 
methods are necessary, especially the use of a reconciled tree that combines 
information from both a species tree and a gene tree.             
 
As the reconstruction of IPMDH could not be taken back to the LCA of the 
Firmicutes, ancestral enzymes from the Bacillus phylogeny were tested for 
activity on alternative substrates for IPMDH to assess how substrate promiscuity 
may have evolved in this enzyme over the last billion years.  IPMDH appears to 
be evolutionarily related to ICD, malate dehydrogenase and tartrate 
dehydrogenase, and exhibits slow turnover of the substrates for these related 
dehydrogenases.  Activity of ancestral IPMDHs was tested against these 
alternative substrates to characterise the evolution of substrate promiscuity in 
IPMDH.  Due to issues encountered in measuring Michaelis-Menten kinetics with 
the alternative substrates, specific activity was measured instead.  ANC1 and the 
contemporary BCVX IPMDH had similar rates of substrate turn over for the 
alternative substrates malate and tartrate.  For ANC4, turnover rates of malate and 
tartrate were significantly faster than for ANC1 and BCVX as expected given the 
faster turnover of natural substrate by ANC4.  However, ANC4 was tenfold 
slower than ANC1 or BCVX at turning over isocitrate.  Given the age of the 
citrate cycle (Cunchillos & Lecointre 2003), isocitrate would likely have been an 
encountered at the time ANC4 was active.  However, without more knowledge of 
the activity demands of ANC4 at the time it was active it is difficult to rationalise 
the slow rate of the enzyme with isocitrate compared to its younger counterparts.  
Overall, these results do not suggest that there is any increase in substrate 
promiscuity in ancestral IPMDH enzymes.  Taken in conjunction with the results 
of Risso et al. (2013) and Wouters et al. (2003), who have shown increased 
substrate promiscuity in ancestral β-lactamases and that enzyme specificity over 
time is not linear in ancestral granzymes respectively, it seems that the evolution 
of substrate promiscuity varies between different enzymes and is not necessarily a 
linear process from generalist to specialist.  It is also possible that this 
reconstruction back to the LCA of the Bacillus has not been taken far enough to 
see the original generalist enzyme that has subsequently specialised in IPM 
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oxidative decarboxylation.  Promiscuity testing of more ancient ancestors, such as 
the LCA of the Firmicutes, may reveal this original generalist activity.          
 
Previous characterisation of the ancestral IPMDHs from Bacillus (Hobbs et al. 
2012) has shown that ANC1 and ANC4 are catalytically faster, and ANC4 is more 
kinetically stable, than their extant counterparts.  To assess why these faster and 
more stable enzymes have been lost over evolutionary time, the effect the 
ancestral enzymes have on growth while functioning within the biosynthetic 
pathway for leucine in a cellular context was measured.  IPMDH enzymes were 
expressed from pPROEX with IPTG induction in the Keio collection E. coli leuB  
KO strain (Baba et al. 2006).  This system has an obvious draw back in the use of 
an overexpression vector, resulting in abnormally high intracellular levels of 
IPMDH.   Ideally genes would be cloned into the genomic DNA to be expressed 
under control of the natural regulation system of the leu operon.  This 
overexpression system was trialled as an initial test for growth rate differences 
between the ancestral and contemporary IPMDH enzymes.  When grown on M9 
agar, obvious differences in the extent of growth were observed.  ANC1 and 
BCVX showed similar levels of growth, while ANC4 had considerably poorer 
growth.  An attempt to fully quantify the growth rates in liquid M9 medium was 
made, however no significant differences in growth rates were able to be 
determined.  However, the growth trend observed in plate growth has 
subsequently been corroborated using a more realistic expression system where 
IPMDH expression under the control of the leu operon promoter was measured 
(Hobbs et al, unpublished).  This trend was likely obscured in the growth rate 
trials with IPMDH overexpression due to the artificially high levels of 
intracellular enzyme.  Abnormal cellular compositions created by IPMDH 
overexpression potentially disrupt normal cellular functions and reduce the 
growth rate differences present between the IPMDH variants.  The system is also 
not guaranteed to give even levels of IPMDH expression across the strains, 
despite equal addition of IPTG.  The decreased growth rate of ANC4 seen in plate 
growth could be due to a number of effects.  The greater rate of substrate turnover 
by ANC4 may deplete cellular concentrations of the cofactor NAD
+
, affecting 
other metabolic pathways dependent on NAD
+
.  The rate of ANC4 may also result 
in the build up of product to levels which have adverse effects on the cell. It may 
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also be the kinetic stability of ANC4 which affects the in vivo fitness, disrupting 
enzyme turnover and thus the overall regulation of the pathway for leucine 
biosynthesis.  The OD overshoot before dropping down to a stable OD that was 
observed in ANC4 growth but not ANC1 or BCVX also suggests a regulation 
issue in the cells.  Although the exact cause of the decreased fitness for ANC4 is 
not known, the decreased in vivo fitness compared to contemporary counterparts 
clarifies why this enzyme has been lost over evolutionary time.  
 
In vivo growth rates were also attempted in E. coli strains with the natural 
dehydrogenases of the alternative substrates tartrate and isocitrate knocked out to 
determine if IPMDH enzymes could complement these losses.  Small amounts of 
growth were observed on M9 agar, however significant growth was not 
measurable for quantitation in liquid medium.  Given the low rates of substrate 
turnover in vitro for the alternative substrates, this inability to complement the KO 
in vivo is not unexpected.  This is especially significant given that the IPMDH 
enzymes in this system are overexpressed, and the higher than natural levels were 
still unable to achieve the substrate turnover necessary to complement the KO and 
support growth.      
 
In the context of the in vivo and in vitro differences between ANC1 and ANC4, 
the X-ray crystal structure of ANC1 was determined to try structurally rationalise 
these differences.  The structure of ANC1 shows close structural homology to 
previously solved IPMDH structures.  Closest structural homology is to ANC4.  
Between the two structures, no differences were found to rationalise the activity 
differences observed between ANC1 and ANC4.  ANC1 is structurally closer to 
contemporary IPMDH structures than ANC4, as expected given the respective 
ages of the two enzymes.  ANC1 also shows the closest structural homology to 
IPMDHs from the thermophilic organisms T. thermophilus, A. ferrooxidans, and 
B. coagulans, suggesting a commonality between IPMDHs of thermophilic origin.   
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5.2 Future research 
Following the successful reconstruction of IPMDH back to the LCA of the 
Firmicutes, this enzyme can now be characterised as ANC1 and ANC4 have been 
in this study in terms of substrate promiscuity and in vivo fitness.  To further 
complete our understanding of IPMDH evolution, ANC2 and ANC3 from Hobbs 
et al. (2012) should also be characterised.  X-ray crystal structures for these 
enzymes, as well as contemporary Bacillus IPMDHs, would also give a more 
complete structural understanding of the evolution of IPMDH. 
 
Given the issues with the in vivo expression system described here, better systems 
are needed to more accurately measure the fitness effects of ancestral IPMDHs.  
Ideally this would involve allelic replacement of the IPMDH genes into a 
thermophilic Bacillus strain.  This would better replicate the cellular conditions 
the enzymes were active within, the temperature that ANC1, ANC4, and BCVX 
are most active at and the natural regulation of the enzyme in the leu operon.  In 
vivo evolution experiments could also complement this fitness work.  This would 
involve following the changes in the leuB gene as well as the whole genome over 
successive generations as adaptive evolution takes place.  This would allow any 
changes arising in ANC4 that increase fitness, to be characterised as the strain 
evolves.   
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Appendices 
Appendix A: Bacterial Strains and Plasmids 
A1: Plasmids and cell strains 
Table A.1: List of plasmids used in study. 
Plasmid Description 
pPROEX HTb E. coli expression vector with trc promotor, 
encoding a N-terminal His-tag: Amp
r
 
 
Table A.2: List of E. coli cell strains used in study. 
Cell strain Description  
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1gyrA96 relA1 
Keio collection – parent 
strain:  E. coli BW25141 
(rrnB3 DElacZ4787 DEphoBR580hsdR514 DE(ar
aBAD)567DE(rhaBAD)568galU95 DEendA9::FR
T DEuidA3::pir(wt) recA1 rph-1 
E. coli BW25141 – leuB KO (rrnB3 DElacZ4787 DEphoBR580hsdR514 DE(ar
aBAD)567DE(rhaBAD)568galU95 DEendA9::FR
T DEuidA3::pir(wt) recA1 rph-1ΔleuB 
E. coli BW25141 – icd KO (rrnB3 DElacZ4787 DEphoBR580hsdR514 DE(ar
aBAD)567DE(rhaBAD)568galU95 DEendA9::FR
T DEuidA3::pir(wt) recA1 rph-1 Δicd 
E. coli BW25141 – yeaU KO (rrnB3 DElacZ4787 DEphoBR580hsdR514 DE(ar
aBAD)567DE(rhaBAD)568galU95 DEendA9::FR
T DEuidA3::pir(wt) recA1 rph-1 ΔyeaU 
E. coli BW25141 – mdh KO (rrnB3 DElacZ4787 DEphoBR580hsdR514 DE(ar
aBAD)567DE(rhaBAD)568galU95 DEendA9::FR
T DEuidA3::pir(wt) recA1 rph-1 Δmdh 
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A2: Genetically modified organisms used in study 
Table A.3: List of transformant cell lines used in this study. 
Cell strain  Plasmid  
E. coli DH5α pPROEX-BCVX 
 pPROEX-ANC1 
 pPROEX-ANC4 
E. coli BW25141 pPROEX 
E. coli BW25141 – leuB KO pPROEX 
 pPROEX-BCVX 
 pPROEX-ANC1 
 pPROEX-ANC4 
E. coli BW25141 – icd KO pPROEX 
 pPROEX-BCVX 
 pPROEX-ANC1 
 pPROEX-ANC4 
E. coli BW25141 – yeaU KO pPROEX 
 pPROEX-BCVX 
 pPROEX-ANC1 
 pPROEX-ANC4 
E. coli BW25141 – mdh KO pPROEX 
 pPROEX-BCVX 
 pPROEX-ANC1 
 pPROEX-ANC4 
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Appendix B: Accession Numbers and Gene Sequences 
B1: Accession numbers of sequences used in study   
Table A.4: Bacterial strains and IPMDH accession numbers. 
Organism Strain/serovar Accession number/source 
B. amyloliquefaciens FZB42 NC_009725 
B. anthracis Ames AE016879 
B. caldotenax Unknown X04762 
B. caldovelox DSM 411 HQ625361 
B. cereus ATCC 14579 AE017002 
B. clausii KSM-K16 NC_006582 
B. coagulans ATCC 7051 M33099 
B. cytotoxicus NVH 391-98 NC_009674 
B. halodurans C-125 AP0001517 
B. licheniformis ATCC 14580 NC_006322 
B. megaterium DSM 319 X65184 
B. pseudomycoides DSM 12442 NZ_ACMX01000029 
B. psychrophilus DSM 3 HQ625362 
B. psychrosaccharolyticus DSM 6 HQ625363 
B. pumilus SAFR-032 NC_009848 
B. stearothermophilus DSM 22 http://www.genome.ou.edu/bstearo.html (contig 446) 
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B. subtilis 168 ZP_03592614 
B. thuringiensis KurstakijT03a001 ZP_04113977 
B. weihenstephanesis KBAB4 CP000903 
C. acetobutylicum ATCC 824 NC_003030 
C. asparagiforme DSM 15981 NZ_ACCJ01000143 
C. bartlettii DSM 16795 NZ_ABEZ02000017          
C. beijerinckii NCIMB 8052 NC_009617 
C. bolteae ATCC BAA-613 NZ_ABCC02000023 
C. botulinum E3 Alaska E43 NC_010723 
C. butyricum 5521 NZ_ABDT01000094          
C. carboxidivorans P7 NZ_ACVI01000012          
C. cellulolyticum H10 NC_011898 
C. celulovorans 743B NC_014393 
C. citroniae WAL-17108 NZ_ADLJ01000014          
C. clariflavum DSM 19732 NC_016627 
C. clostridioforme 2_1_49FAA NZ_ADLL01000027 
C. difficile 002-P50-2011 AGAA01000028 
C. kluyveri DSM 555 NC_009706 
C. lentocellum DSM 5427 NC_015275 
C. leptum DSM 753 NZ_ABCB02000020          
C. ljungdahlii DSM 13528 NC_014328 
C. papyrosolvens DSM 2782 NZ_ACXX02000006          
C. phytofermentans ISDg NC_010001 
C. ramosum DSM 1402 NZ_ABFX02000013        
C. saccharolyticum WM1 NC_014376 
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C. symbiosum WAL-14163 NZ_ADLQ01000063 
C. thermocellum ATCC 27405 NC_009012 
L. lactis KF147 NC_013656 
L. grayi DSM 20601 NZ_ACCR02000003          
L. innocua Clip11262 AL596171 
L. ivanovii PAM 55 NC_016011 
L. monocytogenes EGD-e AL591981                 
L. seeligeri serovar 1/2b SLCC3954 NC_013891 
L. welshimeri serovar 6b SLCC5334 NC_008555 
Staph. aureus H116 DQ413537 
Staph. capitis SK14 NZ_ACFR01000019  
Staph. caprae C87 NZ_GL545274                   
Staph. epidermidis M23864:W1 NZ_ACJB01000008          
Staph. haemolyticus JCSC1435 NC_007168 
Staph. hominis C80 NZ_GL545258              
Staph. lugdunensis VCU139 AHLK01000030 
Staph. pettenkoferi VCU012 AGUA01000088 
Staph. saprophyticus ATCC 15305 NC_007350 
Staph. simiae CCM 7213 NZ_AEUN01000493          
Staph. warneri L37603 NZ_ACPZ01000065          
Strep. australis ATCC 700641 NZ_AEQR01000019          
Strep. criceti HS-6 NZ_AEUV02000002          
Strep. cristatus ATCC 51100 NZ_AEVC01000007          
Strep. downei F0415 NZ_AEKN01000006 
Strep. equinus ATCC 9812 NZ_AEVB01000006          
  
 
1
1
5
 
A
p
p
en
d
ices 
Strep. gallolyticus UCN34 NC_013798 
Strep. gordonii CH1 NC_009785 
Strep. infantis X AFUQ01000003  
Strep. macacae NCTC 11558 NZ_AEUW02000001 
Strep. macedonicus ACA-DC 198 NC_016749 
Strep. mitis SK597 NZ_AEDV01000044         
Strep. mutans UA159 NC_004350 
Strep. oralis ATCC 35037 NZ_ADMV01000020          
Strep. parasanguinis SK236 AFUC01000006     
Strep. pasteurianus ATCC 43144 NC_015600 
Strep. pneumoniae D39 NC_008533 
Strep. salivarius CCHSS3 NC_015760 
Strep. sanguinis ATCC 49296 NZ_AEPO01000014          
Strep. suis R61 AEYY01000041 
Strep. thermophilus LMD-9 NC_008532 
Strep. vestibularis F0396 NZ_AEKO01000005          
T. ethanolicus JW 200 NZ_AEYS01000010 
T. italicus Ab9 NC_013921 
T. pseudethanolicus ATCC 33223 NC_010321 
T. tengcongensis MB4 NC_003869 
T. thermosaccharolyticum DSM 571 NC_014410 
T. wiegelii Rt8.B1 NC_015958 
T. xylanolyticum LX-11 NC_015555 
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B2: LCA sequence information  
The LCA protein sequence was codon optimised for expression in E. coli.  The 
sequence also included an N-terminal hexa-histidine tag for purification purposes. 
 
LCA IPMDH gene sequence optimised for expression in E. coli  
GGATCCATGAAAATGAAAATTGCCGTTATTCCGGGTGATGGTATTGGTCCGGAAA
TTATTGAAGAAGCCATCAAAGTTCTGAATGCCGTGGCAGAAAAATATGGCCTGAA
ATTCGAATATAAAGAGGTTCTGCTGGGAGGTTGTGCAATTGATGAAACCGGTGTT
CCGCTGCCGGAAGAAACCGTTGAAGTTTGTAAAAAAAGTGATGCAGTGCTGCTGG
GTGCAGTTGGTGGTCCGAAATGGGATAATCTGCCGAGCAATAAACGTCCGGAAGC
AGGTCTGCTGGGTATTCGTAAAGGTCTGGGTGTTTATGCAAATCTGCGTCCGGCA
ATTCTGTATCCGGCACTGAAAAGCGCAAGTCCGCTGAAACCGGAAATTCTGGAAG
GTATTGATATTATGGTTGTGCGTGAACTGACCGGTGGTATCTATTTTGGTGAACG
TGGTCGCATTGATATCGGTGGTAAAAAAGCATATGATACCGAGATCTATACCACC
TTTGAAATTGAACGTATTGCCCGTAAAGCATTTGAAGCAGCACGTAAACGTAACA
AAAAACTGACCAGCGTTGATAAAGCCAATGTTCTGGAAAGCAGCCGTCTGTGGCG
TGAAGTTGTTGAAGAAGTTGCAAAAGAATATCCGGATGTGGAACTGAACTATATG
TATGTTGATAATGCAAGCATGCAGCTGATTCGTGATCCGAAACAGTTTGATGTTA
TTGTGACCAGCAATATGTTTGGCGATATTCTGACCGATGAAGCGAGCATGCTGAC
CGGTTCAATTGGTATGCTGCCGAGCGCAAGCCTGCGTGGTGATGGTCCGGGTCTG
TATGAACCGGTGCATGGTAGCGCACCGGATATTGCAGGCCAGAATAAAGCAAATC
CGATTGCAACCATTATGAGCGTTGCAATGATGCTGAAATATAGCTTCGATATGGA
AGAGGCAGCCGATGATATCAAAAATGCCGTTGAAAAAGTTCTGGAAGAGGGTTAT
CGTACCGGTGATATTGCAATTGAAGGCACCAAAATTGTTGGCACCGAAGAAATGG
GTGATCTGATTGTGGAAGATCTGGAAAAAATCTAATAACTGCAG 
 
LCA IPMDH protein sequence 
MKMKIAVIPGDGIGPEIIEEAIKVLNAVAEKYGLKFEYKEVLLGGCAIDETGVPL
PEETVEVCKKSDAVLLGAVGGPKWDNLPSNKRPEAGLLGIRKGLGVYANLRPAIL
YPALKSASPLKPEILEGIDIMVVRELTGGIYFGERGRIDIGGKKAYDTEIYTTFE
IERIARKAFEAARKRNKKLTSVDKANVLESSRLWREVVEEVAKEYPDVELNYMYV
DNASMQLIRDPKQFDVIVTSNMFGDILTDEASMLTGSIGMLPSASLRGDGPSLYE
PVHGSAPDIAGQNKANPIATIMSVAMMLKYSFDMEEAADDIKNAVEKVLEEGYRT
GDIAIEGTKIVGTEEMGDLIVEDLEKI 
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Appendix C: Reagents, Buffers, Gels and Growth Media 
C1:  Reagents and buffers   
10 x DNA loading dye  0.4 % w/v bromophenol blue, 0.4 % w/v xylene, 
50 % v/v glycerol 
 
Assay buffer  20 mM potassium phosphate buffer, pH 7.6, 0.3 
M KCl, 0.2 mM MnCl2 
 
Coomassie stain 0.05 % w/v coomassie blue R-250, 25 % v/v 
isopropanol, 10% v/v acetic acid  
 
Elution buffer 50 mM sodium phosphate buffer, pH 8.0, 300 
mM NaCl, 1 M imidazole 
 
Lysis buffer  50 mM sodium phosphate buffer, pH 8.0, 300 
mM NaCl, 50 mM imidazole 
 
SE buffer 20 mM potassium phosphate buffer, pH 7.6 
 
TAE buffer 40 mM Tris-acetate, 2 mM EDTA. 
C2:  Growth media 
LB 10 g/L bacto tryptone, 5 g/L yeast extract, 10 g/L NaCl, 
pH 7.0 
 
LB agar 10 g/L bacto tryptone, 5 g/L yeast extract, 10 g/L NaCl, 
15 g/L agar, pH 7.0 
 
 
Appendices  
118 
 
 
 
M9 minimal media 5 x M9 salts:   64 g/L Na2HPO4.7H20 
    15 g/L KH2PO4 
     2.5 g/L NaCl  
    5.0 g/L NH4Cl  
   
 M9 media:   200 ml/L 5x M9 salts  
    2 ml/L 1 M MgSO4  
  20 ml/L carbon source (0.2 µm filter     
                 sterilised) 
   0.1 ml/L CaCl2  
   780 ml/L H2O 
   
M9 agar 200 ml/L 5x M9 salts 
 2 ml/L 1 M MgSO4  
 20 ml/L carbon source (0.2 µm filter sterilised) 
 0.1 ml/L CaCl2 
 780 ml/L H2O with 15 g agar  
 
TB Solution A  12 g tryptone 
   24 g yeast extract 
   4 ml glycerol 
   Made up to 900 ml with H2O  
 Solution B  2.31 g KH2PO4 
   12.54 g K2HPO4 
   Made up to 100 ml with H20 
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C3:  Gels 
Agarose gel  1 % w/v agarose, in TAE buffer.  2-5 µL SYBR safe DNA      
                         gel stain (Invitrogen, USA) per gel.   
 
 
SDS-PAGE gel   
Table A.5: SDS-PAGE gel composition 
 Stacker (ml) 12 % gel (ml) 
MQ H2O   8.5   10.05 
Stacking buffer   1.6   - 
Resolving buffer   -   7.5 
30 % acrylamide   2.125   12 
10 % SDS   0.125   0.3 
10 % APS *   0.063   0.15 
TEMED **   0.0063   0.015 
 * APS (ammonium persulphate) 
 ** TEMED (N, N, N’, N’-tetramethylethylenediamine) 
 
 Stacking buffer 1.0 M Tris-HCl, pH 6.8 
 
Resolving buffer 1.5 M Tris-HCl, pH 8.8 
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Appendix D: Growth curves for complemented leuB KOs 
Table A.6: Growth curves of E. coli leuB KOs complemented with BCVX IPMDH  
Internal 
replicate 
 
Biological replicate one 
 
Biological replicate two 
 
Biological replicate three 
 
    1 
   
 
    2 
   
     
    3 
   
Axes are growth time (minutes) and OD (600 nm) for the horizontal and vertical axes respectively.   
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
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Table A.7: Growth curves of E. coli leuB KOs complemented with ANC1 IPMDH 
Internal 
replicate 
 
Biological replicate one 
 
Biological replicate two 
 
Biological replicate three 
 
    1 
   
  
    2 
   
   
    3 
   
     Axes are growth time (minutes) and OD (600 nm) for the horizontal and vertical axes respectively.   
 
0.0 
0.1 
0.2 
0.3 
0.4 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0 200 400 600 800 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 200 400 600 800 1000 
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Table A.8: Growth curves of E. coli leuB KOs complemented with ANC4 IPMDH 
Internal 
replicate 
 
Biological replicate one 
 
Biological replicate two 
 
Biological replicate three 
 
    1 
   
 
    2 
   
 
    3 
   
     Axes are growth time (minutes) and OD (600 nm) for the horizontal and vertical axes respectively.   
 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
0.0 
0.2 
0.4 
0.6 
0 500 1000 
0.0 
0.2 
0.4 
0.6 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
0.0 
0.1 
0.2 
0.3 
0.4 
0 500 1000 
0.0 
0.2 
0.4 
0.6 
0 500 1000 
0.0 
0.2 
0.4 
0.6 
0 500 1000 
0.0 
0.2 
0.4 
0.6 
0 500 1000 
